Other local infections of skin and subcutaneous tissue

L12_INFECT_SKIN_OTHER

Tuberculosis, Cutaneous: Tuberculosis of the skin. It includes scrofuloderma and tuberculid, but not LUPUS VULGARIS.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints L12_PYODERMA L12_ERYTHRASMA L12_INFECT_SKIN_NAS	4462
6. Filter based on genotype QC (FinnGen only)	4300

Control definitions (FinnGen only)

Control exclude: L12_INFECT_SKIN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	L12_INFECT_SKIN_OTHER
CONTROL_EXCLUDE	L12_INFECT_SKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	L12_PYODERMA\|L12_ERYTHRASMA\|L12_INFECT_SKIN_NAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other local infections of skin and subcutaneous tissue based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	34982	15741	18936
Only index persons	29006	13360	15646
Unadjusted period prevalence (%)
Whole population	0.49	0.45	0.53
Only index persons	0.55	0.49	0.60
Median age at first event (years)
Whole population	47.14	48.83	45.62
Only index persons	47.11	49.03	45.48

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4300	2183	2117
Unadjusted period prevalence (%)	0.87	0.77	0.97
Median age at first event (years)	54.61	52.02	57.28

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4461: Matched controls
44610

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L08.0

ICD-10 Finland

Pyoderma

70.4

307.7

545

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

79.1

307.7

1808

381

A46

ICD-10 Finland

Erysipelas

4.6

307.7

1203

3336

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

82.6

307.7

1902

398

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

8.3

302.3

418

550

J01FF01

ATC

clindamycin; systemic

3.3

299.1

1734

7291

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

10.5

281.9

320

326

S97

ICPC

Chronic ulcer skin

5.9

279.7

550

1047

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.2

262.7

478

843

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

10.6

245.4

276

277

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.5

219.7

888

2929

J01DB01

ATC

cefalexin; oral

4.3

199.5

4047

30886

J01CF05

ATC

flucloxacillin; systemic

4.5

185.2

486

1173

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

8.8

180.7

231

274

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

7.4

179.9

270

387

NHQ40

NOMESCO Finland

Amputation of toe

11.2

176.3

188

174

68600

ICD-8 Finland

Other local infections of skin and subcutaneous tissue, Pyoderma

+∞

172.0

164

L03.9

ICD-10 Finland

Cellulitis, unspecified

10.9

170.5

186

178

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.3

160.4

702

2402

E0000UV, ,

ATC

2.3

150.5

2131

12854

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.5

143.5

1140

5333

C03CA01

ATC

furosemide; systemic

2.3

141.4

1494

7931

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.8

139.1

815

3272

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.2

137.3

604

2063

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

135.7

675

2476

L08.1

ICD-10 Finland

Erythrasma

56.3

127.4

S18

ICPC

Laceration/cut

2.1

123.4

2194

14115

J01MA12

ATC

levofloxacin; systemic

2.5

122.0

1001

4711

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

120.7

2204

14281

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

120.0

1158

5848

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.8

118.7

664

2586

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.1

117.5

531

1835

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.4

113.0

230

445

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

11.0

112.5

121

113

N02AX02

ATC

tramadol; systemic, rectal

2.0

111.9

2049

13175

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

13.4

107.6

102

D07AC01

ATC

betamethasone; topical

2.0

105.8

1749

10786

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.8

105.7

167

252

J01MA02

ATC

ciprofloxacin; systemic

2.0

105.7

1860

11727

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.3

102.3

418

1356

A10AE04

ATC

insulin glargine; parenteral

2.8

102.3

559

2142

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.7

100.8

338

965

R60.0

ICD-10 Finland

Localized oedema

2.6

99.9

649

2715

H02AB06

ATC

prednisolone; systemic

1.9

99.1

2226

15148

S76

ICPC

Skin infection other

3.6

97.8

341

999

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

4.4

97.6

254

603

TQW80

NOMESCO Finland

Local dermatologic skincare

5.0

97.5

215

446

A10AB05

ATC

insulin aspart; parenteral

3.0

97.1

467

1666

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.7

95.9

588

2387

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.3

94.1

162

267

L03.0

ICD-10 Finland

Cellulitis of finger and toe

3.0

90.9

448

1618

N02AA05

ATC

oxycodone; systemic

2.3

90.4

872

4343

N03AX16

ATC

[U] pregabalin

2.1

89.6

1124

6204

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

89.4

718

3305

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.6

89.2

173

320

QDA10

NOMESCO Finland

Incision of skin of lower limb

13.4

87.9

J01DA01

ATC

[U] cefalexin

1.9

87.7

2786

20877

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.4

87.6

684

3107

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

86.8

385

1309

68698

ICD-8 Finland

Other local infections of skin and subcutaneous tissue, Aliae definitae

+∞

86.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

84.4

839

4220

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

49.5

84.4

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.2

84.0

176

349

D07AB02

ATC

hydrocortisone butyrate; topical

1.9

83.9

1394

8463

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

81.6

1187

6875

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

16.8

81.5

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

5.1

81.4

174

351

X59

ICD-10 Finland

Exposure to unspecified factor

2.1

81.1

950

5087

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

80.5

530

2219

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.8

80.4

452

1749

E000001, ,

ATC

2.1

80.3

991

5408

D07AB08

ATC

desonide; topical

2.5

79.9

582

2556

R50.9

ICD-10 Finland

Fever, unspecified

2.2

79.8

787

3938

L17

ICPC

Foot/toe symptom/complaint

1.9

78.1

1327

8080

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

78.1

823

4225

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

77.1

656

3083

TQW11

NOMESCO Finland

Vacuum treatment of wound

5.4

76.5

155

298

A10AC01

ATC

insulin (human); parenteral

2.8

76.5

421

1609

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

76.3

1228

7336

127

Kela drug reimbursment

Transplant complication

6.0

76.2

135

229

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

75.5

1131

6590

ZZA00

NOMESCO Finland

Split skin graft

4.4

75.3

191

444

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.3

75.1

625

2908

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.1

74.9

162

330

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

6.7

74.8

120

184

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

72.5

1409

8916

L30.3

ICD-10 Finland

Infective dermatitis

3.8

71.9

227

620

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

5.6

71.5

138

254

L04AA06

ATC

mycophenolic acid; systemic

5.3

71.4

146

283

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

71.3

1392

8813

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

71.3

1308

8122

QBA10

NOMESCO Finland

Incision of skin of trunk

9.9

69.6

Z3231

NOMESCO Finland

Registered nurse

1.9

69.2

1276

7922

ZXD05

NOMESCO Finland

Urgent procedure

1.8

68.6

1387

8853

Z94.0

ICD-10 Finland

Kidney transplant status

7.0

68.6

105

153

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.9

68.3

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.9

68.2

340

1231

H3603, E103,

ICD-10 Finland

8.4

68.1

108

Z49.1

ICD-10 Finland

Extracorporeal dialysis

6.4

67.5

113

181

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

10.6

67.5

SPAT1255

SPAT

Intravenous administration of medicine

2.7

66.5

373

1437

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

66.5

369

1414

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.7

66.2

123

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

65.4

880

4912

M79.6

ICD-10 Finland

Pain in limb

1.7

65.2

1818

12692

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

6.7

64.9

103

156

D09AB01

ATC

zinc bandage without supplements; topical

4.9

64.6

144

301

S29

ICPC

Skin symptom/complaint other

2.0

63.9

884

4977

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.3

63.2

251

796

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

5.2

63.1

132

261

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

62.8

1614

10985

A10AB01

ATC

insulin (human); parenteral

3.6

62.8

216

625

D07AC13

ATC

mometasone; topical

1.8

62.7

1296

8285

N03AX12

ATC

[U] gabapentin; oral

2.0

62.7

766

4127

D07AD01

ATC

clobetasol; topical

2.0

62.1

767

4146

NGQ20

NOMESCO Finland

Amputation of lower leg

12.1

61.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

61.7

763

4126

TK800

NOMESCO Finland

Hemodialysis

4.6

61.6

149

333

L73.2

ICD-10 Finland

Hidradenitis suppurativa

7.9

61.2

108

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

61.1

320

1188

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

60.7

1182

7413

R06AE07

ATC

cetirizine; oral

1.7

60.4

1917

13774

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.9

60.4

107

P01AB01

ATC

metronidazole; oral, rectal

1.7

60.4

1685

11700

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

60.2

176

455

ZX120

NOMESCO Finland

Intravenous

2.4

60.2

470

2117

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.5

59.6

212

627

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.5

59.4

115

212

R06.0

ICD-10 Finland

Dyspnoea

1.8

59.3

1177

7415

J01CE08

ATC

benzathine benzylpenicillin; parenteral

7.0

59.3

130

N02BE01

ATC

paracetamol; systemic, rectal

2.1

59.1

3883

34036

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

58.5

846

4822

D07AA02

ATC

hydrocortisone; topical

2.1

58.0

675

3564

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.1

58.0

124

D06AX01

ATC

fusidic acid; topical

2.3

57.9

466

2126

B01AB05

ATC

enoxaparin; parenteral

1.7

57.5

1336

8794

6860A

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Pyoderma

+∞

57.4

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

57.1

736

4029

L20.0

ICD-10 Finland

Besnier prurigo

2.5

57.1

391

1658

ZXA00

NOMESCO Finland

Right side

1.8

57.1

1146

7230

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

56.9

859

4961

A12AA04

ATC

calcium carbonate; oral

5.3

56.8

115

221

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

56.7

1030

6305

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

56.4

610

3132

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.4

56.4

142

328

A02BC02

ATC

pantoprazole; systemic

1.7

55.8

2892

23378

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

55.5

537

2640

L04AD01

ATC

ciclosporin; systemic

4.6

55.5

133

295

SPAT1262

SPAT

Handing over of treatment supplies

1.9

55.5

790

4470

Z2446

NOMESCO Finland

Social worker

2.6

55.4

351

1434

6869X

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Unspecified local infection of skin and subcutaneous tissue

+∞

55.3

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

55.0

466

2170

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

12.1

54.8

WX213

NOMESCO Finland

Lower leg blockade

7.8

54.8

WX002

NOMESCO Finland

Sedation and analgesia

1.9

54.7

854

4978

L28

ICPC

Limited function/disability (L)

1.9

54.5

774

4374

A10AE05

ATC

insulin detemir; parenteral

2.8

54.3

289

1081

S10

ICPC

Boil/carbuncle

2.8

54.0

280

1033

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.4

53.9

408

1810

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

53.7

236

794

L04AA01

ATC

[U] ciclosporin

5.7

53.7

100

178

L30.4

ICD-10 Finland

Erythema intertrigo

5.5

53.2

103

190

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

53.1

348

1445

R4110

NOMESCO Finland

Physiotherapy

1.7

52.9

1210

7895

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

4.8

52.8

120

255

L04AD02

ATC

tacrolimus; systemic

6.3

52.6

144

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.2

52.5

110

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

52.4

840

4931

V03AE01

ATC

polystyrene sulfonate; oral

5.7

52.1

176

R11

ICD-10 Finland

Nausea and vomiting

2.3

52.1

427

1960

SPAT1151

SPAT

Treatment of major wounds

6.1

52.0

149

T89

ICPC

Diabetes insulin dependent

3.1

52.0

227

761

P19

ICPC

Drug abuse

7.9

51.9

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.5

51.9

182

533

J01DA09

ATC

[U] cefadroxil

1.7

51.6

1156

7491

AA1AD

NOMESCO Finland

CT of head and brain

1.7

51.3

1151

7459

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

51.1

1816

13258

M86.6

ICD-10 Finland

Other chronic osteomyelitis

15.1

51.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

51.1

2270

17491

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.3

51.0

443

2082

137

Kela drug reimbursment

Uraemia requiring dialysis

6.8

50.9

120

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

5.1

50.6

106

210

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

50.4

481

2348

D07BC01

ATC

betamethasone and antiseptics; topical

2.1

50.3

563

2921

XF600

NOMESCO Finland

Bloodpressure measurement

2.5

50.1

327

1354

H02AB04

ATC

methylprednisolone; systemic

2.0

49.7

648

3548

SPAT1254

SPAT

Administration of medicine

1.9

49.7

682

3800

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

20.2

49.5

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

49.5

668

3702

A10AB04

ATC

insulin lispro; parenteral

3.4

49.4

180

540

A28

ICPC

Limited function/disability NOS

1.9

49.2

716

4067

I50.9

ICD-10 Finland

Heart failure, unspecified

2.0

49.1

588

3124

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.3

49.1

190

592

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

6.1

49.0

141

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.3

49.0

187

578

A10AA01, ,

ATC

3.7

48.6

155

426

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

7.1

48.3

105

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

48.0

413

1933

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

47.9

1886

14047

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

16.8

47.9

A41.9

ICD-10 Finland

Sepsis, unspecified

3.3

47.8

190

602

Z3226

NOMESCO Finland

Physiotherapist

1.8

47.8

810

4825

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

47.7

433

2070

L04AX01

ATC

azathioprine; systemic

2.9

47.6

232

827

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

5.8

47.6

152

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

47.6

1782

13111

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.0

47.6

142

A11CC03

ATC

alfacalcidol; systemic

3.8

47.4

145

387

SPAT1263

SPAT

Sampling

1.6

47.4

1774

13047

UJF32

NOMESCO Finland

Coloscopy

1.7

47.3

1089

7083

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

46.7

522

2704

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

46.6

329

1412

ZXA05

NOMESCO Finland

Left side

1.7

46.5

1028

6608

N05AH04

ATC

quetiapine; oral

1.8

45.9

778

4629

R53

ICD-10 Finland

Malaise and fatigue

1.7

45.9

1028

6631

XCK10

NOMESCO Finland

Photography of fundus of eye

2.2

45.7

436

2125

A06AD11

ATC

lactulose; oral

1.9

45.5

633

3536

L03.3

ICD-10 Finland

Cellulitis of trunk

9.4

45.4

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

5.1

45.1

193

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.7

44.8

981

6282

A10AA02, ,

ATC

3.2

44.8

178

564

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

44.7

1490

10623

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

44.7

1545

11111

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

44.6

243

919

J01AA07

ATC

tetracycline; systemic

1.9

44.5

651

3696

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.2

44.4

L73.8

ICD-10 Finland

Other specified follicular disorders

6.1

44.3

128

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.8

44.1

237

890

M04AA01

ATC

allopurinol; systemic

2.0

44.0

572

3122

V03AE02

ATC

sevelamer; oral

9.2

43.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

43.9

686

3976

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.5

42.8

152

449

E000002, ,

ATC

2.0

42.7

501

2636

S21

ICPC

Skin texture symptom/complaint

1.9

42.6

619

3502

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

14.7

42.5

B05DA

ATC

Isotonic solutions

6.7

42.4

101

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

42.1

422

2094

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

42.1

574

3181

N18.0

ICD-10 Finland

End-stage renal disease

5.9

42.1

128

S91.3

ICD-10 Finland

Open wound of other parts of foot

3.6

41.8

142

407

D07CC01

ATC

betamethasone and antibiotics; topical

1.9

41.8

562

3098

J01CF02

ATC

cloxacillin; systemic

3.8

41.7

129

347

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

41.6

407

2001

J02AC01

ATC

fluconazole; systemic

1.6

41.5

1531

11132

E000003, ,

ATC

2.7

41.4

225

850

C03DA01

ATC

spironolactone; oral

2.0

41.1

508

2721

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

41.1

1246

8648

N05BA04

ATC

oxazepam; oral

1.6

40.8

1072

7180

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

9.0

40.7

N18.8

ICD-10 Finland

Other chronic renal failure

3.6

40.7

136

386

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

8.1

40.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.1

40.4

437

2231

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

7.6

40.3

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

40.2

1050

7015

SPAT1211

SPAT

Application of soft bandage

2.1

40.0

398

1968

J01MA14

ATC

moxifloxacin; systemic

2.1

40.0

407

2030

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

40.0

219

830

SPAT1301

SPAT

No procedures

1.6

40.0

1290

9073

X58

ICD-10 Finland

Exposure to other specified factors

1.8

40.0

626

3622

XQ802

NOMESCO Finland

Epicutan test

2.9

39.9

199

718

B05DB

ATC

Hypertonic solutions

6.9

39.8

E000006, ,

ATC

2.3

39.7

308

1377

S19

ICPC

Skin injury other

2.8

39.6

204

749

T90

ICPC

Diabetes non-insulin dependent

1.7

39.5

960

6294

M10.9

ICD-10 Finland

Gout, unspecified

2.3

39.2

320

1461

N05BA01

ATC

diazepam; systemic, rectal

1.9

39.2

556

3116

D07XC01

ATC

betamethasone; topical

1.9

39.1

535

2963

N06AX11

ATC

mirtazapine; oral

1.6

38.9

1388

9979

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

38.8

454

2383

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

38.7

754

4652

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

38.1

3017

25666

N05BB01

ATC

hydroxyzine; systemic

2.3

38.0

292

1300

R4180

NOMESCO Finland

Podiatric therapy

5.0

37.8

164

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

37.7

549

3101

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

37.6

251

1048

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

10.6

37.5

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

37.4

622

3662

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

37.3

1248

8827

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.6

37.3

123

346

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.0

37.2

106

269

N30.0

ICD-10 Finland

Acute cystitis

1.8

37.2

646

3852

A10BA02

ATC

metformin; oral

1.6

37.0

1130

7822

Z2221

NOMESCO Finland

Medical doctor

1.6

37.0

1135

7866

N05CF01

ATC

zopiclone; oral

1.6

36.9

1291

9219

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.0

36.9

163

550

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

7.3

36.8

SPAT1229

SPAT

Assessment of need for aid

2.2

36.8

331

1573

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

6.6

36.6

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.1

36.6

104

N06AB04

ATC

citalopram; systemic

1.7

36.5

851

5504

B03XA02

ATC

darbepoetin alfa; parenteral

3.7

36.5

119

332

E66.8

ICD-10 Finland

Other obesity

2.4

36.3

251

1066

R51.80

ICD-10 Finland

Headache

1.8

36.2

667

4044

N06AX21

ATC

duloxetine; oral

1.9

36.2

498

2760

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

36.1

941

6262

H02AB07

ATC

prednisone; oral

1.8

36.0

569

3296

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.1

36.0

245

D02AE01

ATC

carbamide; topical

2.3

36.0

296

1356

I50.0

ICD-10 Finland

Congestive heart failure

2.2

35.8

307

1431

ZXE00

NOMESCO Finland

One hour or less

1.5

35.7

1583

11884

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.6

35.7

184

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

35.6

218

874

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

35.6

194

734

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

35.5

362

1805

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

35.5

1139

7962

A01

ICPC

Pain general/multiple sites

2.0

35.5

393

2021

WX892

NOMESCO Finland

Monitored bed care

2.1

35.1

346

1704

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

34.9

308

1451

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

34.9

288

1320

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

10.1

34.5

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.7

34.5

112

312

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

34.4

573

3369

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.5

34.3

C07AB07

ATC

bisoprolol; oral

1.5

34.3

1908

14964

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.3

34.3

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.0

34.2

381

1963

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

34.1

149

500

R52.9

ICD-10 Finland

Pain, unspecified

2.0

33.9

416

2217

J01FA06

ATC

roxithromycin; oral

1.5

33.8

1601

12149

JN4AD

NOMESCO Finland

Body CT examination

2.0

33.8

419

2241

W19

ICD-10 Finland

Unspecified fall

1.9

33.7

424

2280

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

33.6

239

1027

M54.5

ICD-10 Finland

Low back pain

1.5

33.6

1440

10700

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

33.6

338

1676

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

8.5

33.5

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.6

33.5

205

822

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

33.3

432

2346

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.6

33.3

114

R03AC02

ATC

salbutamol; inhalant

1.5

33.1

2250

18303

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

33.1

194

761

H04AA01

ATC

glucagon; nasal, parenteral

3.3

33.1

126

389

J01AA02

ATC

doxycycline; systemic

1.5

33.0

3195

27856

H3601, E103,

ICD-10 Finland

5.9

33.0

101

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.4

32.9

188

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.5

32.9

116

341

205

Kela drug reimbursment

Chronic hypertension

1.6

32.9

1027

7115

J01XC01

ATC

fusidic acid; systemic

4.5

32.9

180

ZY010

NOMESCO Finland

Hospital outpatient

2.4

32.8

242

1057

Z72.2

ICD-10 Finland

Drug use

7.8

32.7

XQ848

NOMESCO Finland

Dermatological photography

3.0

32.7

150

517

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.3

32.7

127

397

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

32.6

394

2087

SPAT1260

SPAT

Consultation of another employee

1.7

32.6

717

4554

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.7

32.5

174

652

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

32.5

1528

11556

S20

ICPC

Corn/callosity

3.5

32.4

112

325

J04AB02

ATC

rifampicin; systemic

4.6

32.4

170

WX402

NOMESCO Finland

General anaesthesia

1.6

32.3

878

5885

Z49.2

ICD-10 Finland

Other dialysis

5.9

32.2

100

UKC02

NOMESCO Finland

Cystoscopy

1.7

32.1

654

4068

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

4.3

32.1

196

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

32.1

206

845

N02BF02

ATC

pregabalin; oral

2.3

32.0

261

1191

Z71.8

ICD-10 Finland

Other specified counselling

1.5

31.9

1242

9023

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.6

31.8

184

717

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.4

31.8

116

349

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

31.7

571

3432

N03AX09

ATC

lamotrigine; oral

2.4

31.5

220

938

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.5

31.5

108

312

SPAT1153

SPAT

Removal of sutures

1.5

31.4

1242

9051

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

31.3

367

1923

L12

ICPC

Hand/finger symptom/complaint

1.7

31.0

666

4200

QWC00

NOMESCO Finland

Reoperation for superficial infection in surgery of skin

10.1

30.9

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

7.0

30.9

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

30.9

360

1883

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.0

30.9

228

J01AA04

ATC

lymecycline; systemic

1.8

30.8

545

3257

QCA10

NOMESCO Finland

Incision of skin of upper limb

12.0

30.8

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

30.7

140

481

S06.0

ICD-10 Finland

Concussion

1.9

30.6

453

2565

N05CD07

ATC

temazepam; oral

1.8

30.3

461

2632

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.2

30.3

259

1205

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.9

30.2

236

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

30.2

270

1278

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

30.2

485

2815

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

8.7

30.1

WZC30

NOMESCO Finland

Teaching

1.7

30.1

646

4072

X57

ICD-10 Finland

Unspecified privation

3.2

30.0

118

372

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.5

29.9

186

751

F10.24

ICD-10 Finland

Alcohol depence active use

4.0

29.9

220

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

29.7

704

4552

L60.0

ICD-10 Finland

Ingrowing nail

2.4

29.7

211

907

L03

ICD-10 Finland

Cellulitis

5.0

29.6

127

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

29.5

850

5761

S06

ICPC

Rash localized

2.3

29.5

243

1113

WVA20

NOMESCO Finland

Medicine administration

3.0

29.4

132

450

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

29.3

282

1374

D02AX

ATC

Other emollients and protectives

2.7

29.3

157

589

A07AA02

ATC

nystatin; oral

2.2

29.3

244

1123

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.1

29.3

125

414

ZXA10

NOMESCO Finland

Bilateral

1.6

29.2

728

4765

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.0

29.1

128

431

SPAT1312

SPAT

General health counselling

1.5

28.9

1272

9444

SPAT1216

SPAT

Assessment of functional ability

1.7

28.9

596

3714

QDB10, ,

SPAT

3.8

28.7

231

N02BF01

ATC

gabapentin; oral

2.0

28.7

339

1780

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

10.8

28.7

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.2

28.5

260

1240

G47.3

ICD-10 Finland

Sleep apnoea

1.6

28.4

916

6363

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.8

28.4

233

T82

ICPC

Obesity

2.6

28.4

174

698

B01AA03

ATC

warfarin; systemic

1.6

28.4

737

4869

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.4

28.4

103

309

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

28.2

304

1545

L84

ICD-10 Finland

Corns and callosities

2.6

28.2

160

618

6868X

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Other specified local infections of skin and subcutaneous tissue[ALIAE INFECTIONES LOCALES CUTIS ET SUBCUTIS]

+∞

28.1

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

5.7

28.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.6

28.1

258

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.7

28.0

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

27.9

789

5316

J01EA01

ATC

trimethoprim; systemic

1.5

27.9

973

6873

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

10.8

27.8

A10AE06

ATC

insulin degludec; parenteral

2.6

27.7

157

606

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

27.6

200

867

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.6

27.6

A02BC05

ATC

esomeprazole; systemic

1.4

27.5

1584

12357

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

25.5

27.4

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

27.4

496

2978

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

27.4

723

4792

N06AB03

ATC

fluoxetine; oral

1.8

27.4

490

2933

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

4.1

27.3

190

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.0

27.3

119

399

WX320

NOMESCO Finland

Spinalanesthesy

1.5

27.3

931

6543

A02BC01

ATC

omeprazole; systemic

1.5

27.2

1058

7642

WX214

NOMESCO Finland

Plexus blockade at the ankle

6.8

27.1

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.6

27.1

162

642

N06AX16

ATC

venlafaxine; oral

1.7

27.0

566

3537

A10BH05

ATC

linagliptin; oral

2.3

27.0

212

951

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

27.0

2308

19279

XQ800

NOMESCO Finland

Prick test

2.0

27.0

311

1619

L04AX03

ATC

methotrexate; systemic

1.8

27.0

396

2234

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.1

26.8

115

382

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

26.7

1883

15201

C08CA01

ATC

amlodipine; oral

1.4

26.7

1442

11100

E000007, ,

ATC

2.2

26.6

228

1061

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.8

26.6

136

498

S01

ICPC

Pain/tenderness of skin

2.3

26.5

201

889

N05AH03

ATC

olanzapine; systemic

2.1

26.5

269

1338

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.9

26.4

199

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

26.4

686

4526

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

26.2

1954

15910

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

26.2

515

3162

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.4

26.2

290

N05AA02

ATC

levomepromazine; systemic

2.4

26.1

176

739

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

26.0

1414

10885

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

25.9

126

449

L03.2

ICD-10 Finland

Cellulitis of face

7.7

25.9

N03AE01

ATC

clonazepam; systemic

2.1

25.8

245

1187

N05AX12

ATC

aripiprazole; systemic

2.4

25.8

177

749

D11AH01

ATC

tacrolimus; topical

4.6

25.6

131

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

25.6

1091

8014

D05BB02

ATC

acitretin; oral

3.0

25.3

113

384

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.4

25.2

180

776

L30.0

ICD-10 Finland

Nummular dermatitis

2.4

25.1

174

739

NH3BG

NOMESCO Finland

MRI of foot

6.6

25.1

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.6

25.1

151

601

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.2

25.1

228

1087

N03AG01

ATC

valproic acid; systemic, rectal

2.1

25.0

250

1236

E87.5

ICD-10 Finland

Hyperkalaemia

3.4

25.0

264

A41.8

ICD-10 Finland

Other specified sepsis

3.4

25.0

269

EBA00

NOMESCO Finland

Extraction of tooth

1.4

24.9

1428

11077

D01AC02

ATC

miconazole; topical

1.9

24.9

314

1686

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

24.8

304

1615

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

24.8

277

1426

M25.5

ICD-10 Finland

Pain in joint

1.4

24.8

1230

9294

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

9.1

24.7

C09AA02

ATC

enalapril; systemic

1.6

24.7

721

4882

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

24.7

239

1167

H3600, E103,

ICD-10 Finland

4.3

24.6

152

WX882

NOMESCO Finland

High dependency care

2.6

24.6

143

559

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

4.1

24.5

161

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

4.1

24.5

161

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.0

24.5

111

381

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

24.4

2197

18382

X84

ICD-10 Finland

Intentional self-harm by unspecified means

9.4

24.4

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

24.4

206

953

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

24.3

504

3136

XQ902

NOMESCO Finland

Other photography

5.4

24.3

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.5

24.3

133

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.9

24.1

185

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.4

24.1

138

WW200

NOMESCO Finland

Immunization

2.7

23.9

128

480

NH1AD

NOMESCO Finland

Ankle and foot CT

3.0

23.9

106

359

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

3.7

23.9

209

L03.8

ICD-10 Finland

Cellulitis of other sites

8.1

23.9

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

6.0

23.8

A04

ICPC

Weakness/tiredness general

1.6

23.8

581

3769

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

23.8

283

1489

ZXD35

NOMESCO Finland

Usual procedure

2.6

23.8

144

575

QDE35

NOMESCO Finland

Repair of skin defect in lower limb after surgery or injury

7.4

23.7

JN4BD

NOMESCO Finland

Extensive body CT

1.8

23.7

401

2358

RD210, ,

NOMESCO Finland

3.1

23.7

324

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

8.6

23.6

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

23.6

2787

24318

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

23.6

294

1571

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.8

23.6

188

QXB99, ,

SPAT

3.0

23.6

103

346

J05AB01

ATC

aciclovir; systemic

1.5

23.6

830

5851

T74.1

ICD-10 Finland

Physical abuse

3.3

23.6

269

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.0

23.5

279

1466

RS220, ,

NOMESCO Finland

3.8

23.5

193

R02

ICPC

Shortness of breath/dyspnoea

1.7

23.5

495

3094

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

23.5

194

890

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

23.4

283

1497

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

23.4

282

1490

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

23.4

239

1191

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

6.7

23.4

XQ855

NOMESCO Finland

Skin temperature measurement

7.5

23.3

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

9.7

23.2

A08

ICPC

Swelling

2.2

23.2

203

953

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

8.4

23.1

NF3AA

NOMESCO Finland

Femur X-ray examination

3.1

23.1

324

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

23.0

334

1875

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

3.5

23.0

224

R42

ICD-10 Finland

Dizziness and giddiness

1.5

23.0

851

6057

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.2

23.0

143

N06AA09

ATC

amitriptyline; systemic

1.8

23.0

362

2084

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.2

22.9

294

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.2

22.8

148

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

22.8

1064

7924

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

6.3

22.7

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.0

22.6

158

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.2

22.5

292

F61.0

ICD-10 Finland

Mixed personality disorders

3.4

22.5

237

B01AC04

ATC

clopidogrel; oral

1.6

22.5

600

3973

TPX15

NOMESCO Finland

Removal of vascular injection port

6.0

22.5

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.3

22.3

258

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

22.3

248

1275

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

22.2

428

2610

K07

ICPC

Swollen ankles/oedema

2.2

22.1

181

827

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.1

22.0

291

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

22.0

906

6584

R4190

NOMESCO Finland

Nutritional therapy

2.3

21.9

170

759

A10AD01

ATC

insulin (human); parenteral

3.3

21.9

256

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

21.9

355

2060

K08.3

ICD-10 Finland

Retained dental root

1.9

21.9

297

1632

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

21.8

943

6914

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

21.8

253

1320

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

21.7

294

1614

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

18.5

21.7

WX704

NOMESCO Finland

Intubation

1.8

21.6

317

1785

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

21.6

226

1136

A10BB12

ATC

glimepiride; oral

2.0

21.6

256

1345

SPAT1172

SPAT

Guidance concerning hydration

3.0

21.6

321

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

8.8

21.5

NFQ20

NOMESCO Finland

Amputation of femur

5.3

21.5

M10.0

ICD-10 Finland

Idiopathic gout

2.4

21.5

152

652

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.5

21.5

H3603, E113,

ICD-10 Finland

4.7

21.5

105

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

21.4

157

685

B01AB10

ATC

tinzaparin; parenteral

1.7

21.3

382

2282

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

7.9

21.3

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

21.3

180

834

K02.1

ICD-10 Finland

Caries of dentine

1.4

21.2

2360

20232

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

21.2

1011

7545

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

21.2

386

2316

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.6

21.2

193

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.8

21.2

170

L14

ICPC

Leg/thigh symptom/complaint

1.8

21.2

303

1693

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.7

21.2

116

441

J04BA02

ATC

dapsone; oral

5.7

21.1

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.2

21.0

273

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.7

21.0

388

2338

D05AX52

ATC

calcipotriol, combinations; topical

2.0

20.9

219

1101

WX290

NOMESCO Finland

Other blockage of nerve

1.4

20.9

1841

15219

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

20.9

858

6224

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.3

20.9

128

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

20.8

511

3316

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

3.3

20.7

235

R03BB04

ATC

tiotropium bromide; inhalant

1.7

20.7

380

2286

L01BA01

ATC

methotrexate; systemic

2.3

20.6

151

658

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.1

20.6

201

985

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

20.6

856

6223

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

20.6

759

5388

R33

ICD-10 Finland

Retention of urine

1.8

20.6

313

1783

P80

ICPC

Personality disorder

6.3

20.5

C08CA13

ATC

lercanidipine; oral

1.6

20.5

523

3422

S71.1

ICD-10 Finland

Open wound of thigh

4.1

20.5

134

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.2

20.4

263

B01AB04

ATC

dalteparin; parenteral

2.1

20.3

204

1010

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

20.3

863

6297

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.6

20.2

185

R06AX22

ATC

ebastine; oral

1.5

20.1

641

4410

L03

ICPC

Low back symptom/complaint

1.4

20.1

1040

7868

RJ420, ,

NOMESCO Finland

6.4

20.1

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.5

20.0

191

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

20.0

216

1098

R03DC03

ATC

montelukast; oral

1.5

19.9

627

4304

C02AC05

ATC

moxonidine; oral

2.1

19.9

186

897

R03AC13

ATC

formoterol; inhalant

2.1

19.8

195

958

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.9

19.8

151

S22

ICPC

Nail symptom/complaint

1.9

19.7

247

1322

Z00.0

ICD-10 Finland

General medical examination

1.5

19.7

739

5259

SPAT1310

SPAT

Counselling related to known health issue

1.4

19.7

1211

9433

N07BB01

ATC

disulfiram; oral

2.2

19.6

177

841

C08CA05

ATC

nifedipine; systemic

1.9

19.6

237

1253

WW500

NOMESCO Finland

Blood transfusion

2.2

19.6

164

756

D11

ICPC

Diarrhoea

1.6

19.6

450

2869

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

16.4

19.6

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

19.6

2899

25797

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

19.6

301

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

19.6

378

2305

M48.0

ICD-10 Finland

Spinal stenosis

1.6

19.5

439

2784

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

19.5

216

1108

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

19.5

275

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.9

19.5

307

J01CA04

ATC

amoxicillin; systemic

1.4

19.5

3392

30958

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

19.4

134

569

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

19.4

186

905

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

19.4

405

2520

S04

ICPC

Lump/swelling localized

1.7

19.4

394

2436

3AC01, ,

NOMESCO Finland

4.0

19.3

136

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

5.1

19.3

Z29

ICPC

Social problem NOS

2.8

19.2

348

S11

ICPC

Skin infection post-traumatic

3.6

19.2

173

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

19.2

578

3928

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

19.1

348

2087

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.4

19.1

133

567

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.7

19.0

104

395

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

19.0

1063

8139

J01XX08

ATC

linezolid; systemic

5.0

19.0

SPAT1240

SPAT

Therapeutic discussion

1.7

19.0

404

2526

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

19.0

220

1147

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.9

18.9

250

1362

B07.9

ICD-10 Finland

Verruca simplex

2.3

18.9

150

677

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.5

18.9

117

473

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

18.9

808

5896

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.9

18.9

302

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

18.8

787

5715

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

18.8

239

1285

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

18.8

125

522

A10BH01

ATC

sitagliptin; oral

1.7

18.8

347

2089

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

18.8

230

1222

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

15.9

18.8

R5110, ,

SPAT

1.9

18.7

241

1302

L73.9

ICD-10 Finland

Follicular disorder, unspecified

5.6

18.7

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

7.0

18.6

M05BA04

ATC

alendronic acid; oral

1.8

18.6

293

1685

SFA10

NOMESCO Finland

One-surface restoration

1.3

18.6

2151

18400

S09

ICPC

Infected finger/toe

2.3

18.6

135

587

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

18.4

266

1490

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

18.4

495

3276

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

18.4

291

1676

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

3.8

18.4

150

NH3CG

NOMESCO Finland

Extensive MRI of foot

5.5

18.3

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.1

18.3

243

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.1

18.3

238

V03AE03

ATC

lanthanum carbonate; oral

6.6

18.3

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

18.3

168

805

M03BX02

ATC

tizanidine; oral

1.3

18.3

2414

21020

N05AX08

ATC

risperidone; systemic

1.8

18.2

307

1801

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

18.2

420

2679

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

18.2

256

1423

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.2

18.2

234

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.5

18.1

180

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

18.1

259

1448

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.9

18.1

304

N02AC04

ATC

dextropropoxyphene; oral

2.3

18.0

138

614

H05BX01

ATC

cinacalcet; oral

4.9

18.0

H01

ICPC

Ear pain/earache

1.6

18.0

428

2751

B35.3

ICD-10 Finland

Tinea pedis

2.1

17.9

180

892

M01AE02

ATC

naproxen; oral, rectal

1.3

17.9

2217

19107

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.6

17.9

104

408

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

5.1

17.9

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.1

17.9

L40.8

ICD-10 Finland

Other psoriasis

4.3

17.8

109

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

17.8

366

2269

A02BC03

ATC

lansoprazole; oral

1.4

17.8

1046

8065

M86.8

ICD-10 Finland

Other osteomyelitis

18.1

17.7

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.3

17.7

197

S81.9

ICD-10 Finland

Open wound of lower leg, part unspecified

4.1

17.7

118

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

4.1

17.7

118

L28.1

ICD-10 Finland

Prurigo nodularis

4.5

17.7

6851A

ICD-9 Finland

Pilonidal cyst, Without mention of abscess

+∞

17.7

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.6

17.7

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

17.7

208

1090

P15

ICPC

Chronic alcohol abuse

2.4

17.6

126

544

A04AA01

ATC

ondansetron; systemic, rectal

1.8

17.6

290

1691

K10.3

ICD-10 Finland

Alveolitis of jaws

2.0

17.6

182

912

M86.1

ICD-10 Finland

Other acute osteomyelitis

14.6

17.6

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

17.6

210

1107

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

4.4

17.5

A03

ICPC

Fever

1.5

17.5

641

4532

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.6

17.5

160

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

17.5

1000

7670

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

17.5

176

873

CKC12

NOMESCO Finland

Photocoagulation of retina

2.1

17.4

163

786

Y96.9

ICD-10 Finland

Unspecified type of accident

2.9

17.4

294

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

17.4

147

682

R4120

NOMESCO Finland

Occupational therapy

1.8

17.3

253

1423

R03BA02

ATC

budesonide; inhalant

1.5

17.3

666

4754

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

5.3

17.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

17.3

1484

12123

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

17.3

877

6590

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

17.3

863

6467

N06AA12

ATC

doxepin; systemic

2.0

17.2

192

988

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

17.2

346

2131

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.9

17.2

274

ZYC01

NOMESCO Finland

Remote contact by phone

1.9

17.2

226

1230

SPAT1167

SPAT

Insertion of urinary catheter

2.4

17.1

122

526

K03.66

ICD-10 Finland

Tooth plaque

1.7

17.1

291

1712

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

17.1

155

739

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

17.1

269

1548

RS221, ,

NOMESCO Finland

3.1

17.0

233

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

17.0

1552

12782

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.9

17.0

206

1091

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

16.9

440

2888

R31

ICD-10 Finland

Unspecified haematuria

1.6

16.9

378

2392

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.6

16.9

100

396

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.0

16.9

R06AE09

ATC

levocetirizine; oral

1.5

16.9

545

3754

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.7

16.8

141

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.7

16.8

PE1AT

NOMESCO Finland

Femoral artery PTA

3.6

16.8

155

H3600, E113,

ICD-10 Finland

3.5

16.7

160

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

16.7

799

5936

P99

ICPC

Psychological disorders other

2.3

16.7

122

532

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.0

16.7

119

6861A

ICD-9 Finland

Other local infections of skin and subcutaneous tissue, Pyogenic granuloma

+∞

16.7

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

16.6

514

3506

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

16.6

325

1987

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

16.6

153

734

J05AB11

ATC

valaciclovir; oral

1.5

16.6

517

3532

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

16.6

871

6576

SPAT1125

SPAT

Stoma care and guidance

3.1

16.6

226

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.3

16.6

129

578

N19

ICD-10 Finland

Unspecified kidney failure

2.2

16.6

136

623

R03BA05

ATC

fluticasone; inhalant

1.5

16.5

676

4879

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.7

16.5

319

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

16.5

198

1045

N05CF02

ATC

zolpidem; oral

1.5

16.5

630

4487

WX204

NOMESCO Finland

Axillary plexus blockaced

2.2

16.5

132

599

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.0

16.4

116

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.4

16.4

114

486

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

16.4

755

5569

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

16.4

192

1005

Z50.1

ICD-10 Finland

Other physical therapy

1.9

16.4

203

1083

RJ411, ,

NOMESCO Finland

5.0

16.4

E86

ICD-10 Finland

Volume depletion

2.5

16.4

101

408

SPAT1234

SPAT

Support of social functional capacity

1.9

16.3

195

1028

P29

ICPC

Psychological sympt/compl other

1.8

16.3

260

1501

C10AC01

ATC

colestyramine; oral

2.4

16.3

106

439

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

16.3

165

821

R07.3

ICD-10 Finland

Other chest pain

1.6

16.3

376

2399

K65.0

ICD-10 Finland

Acute peritonitis

3.6

16.2

149

A10BK01

ATC

dapagliflozin; oral

1.8

16.2

258

1489

C08CA02

ATC

felodipine; oral

1.7

16.1

328

2026

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.9

16.1

M86.4

ICD-10 Finland

Chronic osteomyelitis with draining sinus

30.1

16.1

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

16.1

139

651

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.5

16.1

155

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.5

16.0

394

L85.3

ICD-10 Finland

Xerosis cutis

3.6

16.0

141

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.2

16.0

136

632

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

16.0

1519

12553

N05AD01

ATC

haloperidol; systemic

2.3

16.0

118

517

B03XA01

ATC

erythropoietin; parenteral

4.0

16.0

114

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

16.0

343

2149

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

16.0

165

827

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.0

15.9

177

910

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

15.9

523

3613

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

15.9

244

1393

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.9

15.9

119

S87

ICPC

Dermatitis/atopic eczema

2.5

15.9

101

414

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

3.3

15.8

181

S80.0

ICD-10 Finland

Contusion of knee

1.7

15.8

275

1628

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

15.8

170

864

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

12.2

15.8

A10AD05

ATC

insulin aspart; parenteral

2.9

15.8

265

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

15.7

166

838

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

15.7

307

1877

SFA30

NOMESCO Finland

Three-surface restoration

1.3

15.7

1573

13091

D03BA52

ATC

collagenase, combinations; topical

4.9

15.7

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.9

15.6

193

1029

N06AB10

ATC

escitalopram; oral

1.4

15.5

744

5522

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

15.5

1512

12528

J46

ICD-10 Finland

Status asthmaticus

2.4

15.5

110

474

L72.1

ICD-10 Finland

Trichilemmal cyst

1.8

15.5

242

1389

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

15.5

135

634

L70.0

ICD-10 Finland

Acne vulgaris

2.4

15.5

102

425

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

15.4

126

H36.01

ICD-10 Finland

Diabetic maculopathy

3.2

15.4

194

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

15.4

155

769

ZZR00

NOMESCO Finland

Flap of skin

2.6

15.4

343

R55

ICD-10 Finland

Syncope and collapse

1.6

15.3

387

2521

L30.8

ICD-10 Finland

Other specified dermatitis

2.4

15.3

108

464

J01MA06

ATC

norfloxacin; oral

1.5

15.3

443

2977

N03AF01

ATC

carbamazepine; oral, rectal

1.9

15.3

185

980

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.3

15.3

180

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.7

15.3

304

J01CA08

ATC

pivmecillinam; oral

1.3

15.2

1357

11100

R35

ICD-10 Finland

Polyuria

1.8

15.2

248

1442

J02AC02

ATC

itraconazole; systemic

1.4

15.2

620

4469

M14.6

ICD-10 Finland

Neuropathic arthropathy

28.7

15.2

M02AA07

ATC

piroxicam; topical

1.3

15.2

1291

10489

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

15.1

203

1113

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

15.1

484

3325

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.2

15.1

126

582

C01DA14

ATC

isosorbide mononitrate; oral

1.5

15.1

527

3686

A10BJ06

ATC

semaglutide; parenteral

1.9

15.0

183

971

E87.6

ICD-10 Finland

Hypokalaemia

2.2

15.0

128

596

C09AA05

ATC

ramipril; oral

1.4

15.0

872

6684

OAB50, ,

SPAT

1.9

15.0

205

1130

C07AB02

ATC

metoprolol; systemic

1.4

15.0

693

5110

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

14.9

116

520

TK810

NOMESCO Finland

Hemofiltration

4.7

14.9

W17

ICD-10 Finland

Other fall from one level to another

2.0

14.9

166

855

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

6.8

14.8

9731

FHL

Opening and channeling of the inflammatory site in the operating room or anesthesia

6.8

14.8

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

14.8

213

1193

A01AB09

ATC

miconazole; local oral

1.7

14.8

298

1837

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

2.8

14.8

264

R06AX27

ATC

desloratadine; oral

1.3

14.7

1057

8369

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

14.7

197

1078

J01FA01

ATC

erythromycin; systemic

1.5

14.7

492

3408

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

14.7

331

2097

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.8

14.7

211

1181

A29

ICPC

General symptom/complaint other

1.5

14.7

448

3045

Z43.5

ICD-10 Finland

Attention to cystostomy

4.6

14.7

U04

ICPC

Incontinence urine

1.9

14.7

188

1015

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

14.6

405

2694

ZX112

NOMESCO Finland

Subcutaneous

2.5

14.6

352

-, ,

ICD-10 Finland

2.5

14.6

376

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

14.6

328

2079

M01AB05

ATC

diclofenac; systemic, rectal

1.3

14.5

2573

22961

SPAT1252

SPAT

Overall medication plan or its review

1.8

14.5

238

1386

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

14.5

167

870

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.0

14.5

100

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

14.5

141

692

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

6.6

14.5

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

1324

3834

4.49

307.65

2.9

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1309

4600

3.61

302.43

3.1

1.9

—

(3023368) Bacteria identified in Blood by Culture

1947

9158

3.00

270.11

6.5

4.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2522

16759

2.16

134.13

9.1

6.3

—

(3006315) Basophils [#/volume] in Blood

2639

17867

2.17

133.46

9.0

5.8

0.04

e9/l

0.75

2323

15439

(3001604) Monocytes [#/volume] in Blood

2634

17835

2.16

132.97

9.0

5.8

0.60

0.58

e9/l

3.68

2321

15418

(3013115) Eosinophils [#/volume] in Blood

2702

18492

2.17

132.48

9.3

6.0

0.21

0.19

e9/l

4.13

2420

16228

(3019198) Lymphocytes [#/volume] in Blood

2688

18380

2.16

131.81

9.0

5.8

1.83

1.94

e9/l

4.36

2431

16270

(3013650) Neutrophils [#/volume] in Blood by Automated count

2903

20624

2.17

126.60

13.0

8.8

4.34

4.07

e9/l

7.16

2580

17952

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2626

18050

2.11

123.65

8.3

6.2

10.55

11.77

umol/l

6.07

2527

17135

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1121

5528

2.37

123.20

2.4

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2896

20684

2.14

122.73

8.4

4.7

7.06

6.67

mmol/l

11.48

2759

19345

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2526

17147

2.09

122.58

12.7

6.7

1.21

mmol/l

3.88

2224

14618

(3006504) Eosinophils/100 leukocytes in Blood

2463

16711

2.06

117.87

9.2

6.0

2.88

2.85

0.22

2325

15633

(3019069) Monocytes/100 leukocytes in Blood

2473

16823

2.05

117.25

9.5

6.3

8.62

8.61

0.05

2339

15781

(3022096) Basophils/100 leukocytes in Blood

2403

16207

2.05

116.34

9.1

6.0

0.66

0.67

0.34

2268

15140

(3018010) Neutrophils/100 leukocytes in Blood

2486

17053

2.03

113.85

9.0

5.9

58.78

56.91

12.16

2352

16011

(3002030) Lymphocytes/100 leukocytes in Blood

2515

17328

2.03

113.71

9.2

6.1

26.17

28.17

16.13

2381

16290

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2320

15553

2.02

113.04

11.2

6.0

1.21

mmol/l

2.69

2168

14237

(3021447) Carbon dioxide [Partial pressure] in Venous blood

757

3262

2.59

110.39

8.2

4.1

5.89

5.83

kpa

0.92

735

3164

(3022217) INR in Platelet poor plasma by Coagulation assay

2357

15986

2.01

110.03

19.3

14.7

1.26

1.27

inr

0.25

617

4700

(3024561) Albumin [Mass/volume] in Serum or Plasma

2234

14912

2.00

108.69

8.1

4.9

34.40

35.73

g/l

20.91

2108

13882

(3002032) Base excess in Venous blood by calculation

749

3255

2.56

107.08

8.5

4.1

1.91

mmol/l

0.02

667

2718

(3012544) pH of Venous blood

762

3382

2.51

103.96

8.4

4.0

7.35

7.38

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

991

4946

2.29

103.74

4.2

2.4

2.27

2.34

g/l

3.14

929

4579

(3022948) Iron [Moles/volume] in Serum or Plasma

1051

5383

2.25

103.32

4.2

2.4

11.42

13.39

umol/l

15.83

994

5028

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

940

4621

2.31

101.78

4.3

2.5

20.49

23.26

7.89

815

3961

(3014111) Lactate [Moles/volume] in Serum or Plasma

699

3018

2.56

100.88

10.4

7.3

1.31

1.36

mmol/l

0.66

681

2938

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

812

3772

2.41

99.96

2.2

1.7

—

(3000991) Gas panel - Venous blood

687

2965

2.56

99.11

13.2

8.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

717

3163

2.51

98.73

13.7

7.5

11.11

9.44

mmol/l

7.46

687

3022

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

805

3791

2.37

95.73

2.2

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1047

5621

2.13

89.81

5.2

3.6

0.80

0.82

mmol/l

5.28

987

5280

(3024354) Oxygen [Partial pressure] in Venous blood

623

2686

2.53

89.51

6.9

3.6

4.85

4.63

kpa

1.48

601

2602

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

581

2432

2.60

88.73

1.9

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3391

27106

2.05

88.35

11.5

7.3

82.12

78.27

u/l

5.02

3247

25599

(3003458) Phosphate [Moles/volume] in Serum or Plasma

899

4580

2.21

87.95

12.4

5.9

1.10

1.05

mmol/l

4.99

855

4278

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1311

7702

1.99

87.54

2.2

1.8

1.25

1.22

mg/l

0.09

1030

5823

(3026008) Bacteria identified in Urine by Culture

1603

10100

1.92

86.92

4.0

3.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2997

23122

1.90

84.61

6.4

4.3

1686.17

1473.48

e6/l

0.05

314

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1437

8834

1.92

83.17

3.0

2.2

3.04

2.91

mg/l

1.40

1273

7535

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1676

10861

1.87

82.19

3.7

2.5

57.52

66.61

u/l

0.63

1572

10052

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1607

10318

1.87

80.82

2.7

2.1

192.81

233.31

u/l

1.13

1528

9713

(3000494) Fungus identified in Specimen by Culture

813

4108

2.20

80.50

1.7

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1055

5914

2.03

79.25

3.7

2.7

1.32

1.15

e6/l

0.47

643

3358

(3044640) Blood type and Crossmatch panel - Blood

1691

11088

1.85

79.11

3.6

2.4

—

(3030467) Casts [#/volume] in Urine by Automated count

1529

9734

1.87

78.47

4.7

3.1

0.46

0.41

e6/l

0.31

1217

7397

(3002582) Erythrocytes [#/volume] in Urine

1632

10645

1.84

77.19

4.8

3.2

98.48

89.56

e6/l

0.05

1303

8170

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2290

16561

1.79

76.40

3.6

2.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3078

24391

1.84

74.54

6.1

4.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

475

1957

2.60

74.36

2.0

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

990

5536

2.01

74.27

3.9

2.9

2.89

2.29

e6/l

1.07

582

2999

(3018095) Leukocytes [#/volume] in Urine

1823

12447

1.79

72.98

5.5

3.6

111.53

100.30

e6/l

0.11

1379

8784

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

443

1782

2.65

72.74

10.4

4.5

24.17

24.07

mmol/l

0.26

435

1749

(3018418) pH of Serum or Plasma

1541

10023

1.82

72.51

7.3

3.9

7.39

7.40

2.16

270

1939

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1968

13824

1.76

70.75

2.3

1.9

95.38

95.49

pmol/l

0.04

1067

7326

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1461

9409

1.82

70.62

3.8

3.1

2260.44

1369.28

ng/l

3.92

1263

8008

(40758558) Short blood count panel - Blood

1401

8944

1.83

69.46

10.1

6.6

—

(3027801) Oxygen [Partial pressure] in Arterial blood

757

3927

2.12

69.16

10.2

7.5

12.03

12.51

kpa

1.81

718

3743

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

757

3929

2.12

69.06

10.2

7.5

5.16

5.08

kpa

1.15

718

3745

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1346

8507

1.83

68.84

3.5

2.3

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3229

26252

1.83

68.49

5.5

3.9

15.09

11.47

mm/h

24.59

3029

24348

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

466

1976

2.52

68.48

1.7

1.5

—

(3003396) Base excess in Arterial blood by calculation

753

3919

2.11

68.12

10.2

7.5

0.82

1.03

mmol/l

0.77

615

3078

(36304419) Bacteria [Presence] in Urine

1465

9524

1.80

68.10

4.6

3.0

—

(3033658) Prothrombin time (PT) actual/Normal

1384

8989

1.78

63.65

6.8

4.1

88.32

89.76

1.26

1356

8768

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1686

11604

1.73

63.10

4.4

3.2

32.64

35.68

u/l

0.90

1602

11040

(3009508) Creatinine [Moles/volume] in Urine

1600

10868

1.74

62.69

4.6

3.2

7.31

7.84

mmol/l

4.72

1357

9237

(3004119) Hemoglobin [Mass/volume] in Venous blood

466

2056

2.41

62.61

6.8

3.5

123.24

129.94

g/l

7.29

458

1998

(3016502) Oxygen saturation in Arterial blood

678

3498

2.11

62.34

10.8

8.0

95.38

95.79

0.92

654

3368

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

738

3946

2.04

61.57

4.4

244.00

243.12

u/l

0.05

716

3724

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

634

3211

2.14

61.10

2.8

2.3

0.21

0.22

g/l

2.09

586

3003

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

170

424

4.13

61.05

8.5

6.9

12.13

11.72

mg/l

0.56

162

397

(3021960) Folate [Moles/volume] in Serum or Plasma

1230

7794

1.80

61.04

1.7

1.5

20.43

20.28

nmol/l

0.12

1073

6683

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1959

14194

1.68

59.54

3.1

2.2

74.02

76.39

nmol/l

3.40

1787

12826

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

306

1139

2.81

58.12

2.6

2.3

622.28

483.05

ug/l

0.30

293

1063

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2089

15456

1.66

58.08

4.3

2.8

131.72

125.85

ug/l

0.49

1971

14333

(3018677) aPTT in Platelet poor plasma by Coagulation assay

922

5419

1.88

57.96

2.9

2.3

30.05

29.79

0.67

892

5255

(3027945) Reticulocytes/100 erythrocytes in Blood

716

3871

2.01

57.61

3.2

2.7

1.80

1.76

0.48

647

3431

(3026493) Urate [Moles/volume] in Serum or Plasma

1379

9194

1.72

56.47

3.7

2.7

2208.25

4729.90

umol/l

2.58

1207

8109

(3002173) Hemoglobin [Mass/volume] in Arterial blood

624

3238

2.08

56.10

11.2

8.3

119.47

122.60

g/l

3.11

612

3149

(3000850) Epithelial cells [#/volume] in Urine

1160

7394

1.77

55.55

3.7

2.5

6.13

5.45

e6/l

0.71

1050

6633

(3026250) Tacrolimus [Mass/volume] in Blood

156

6.20

55.36

35.3

33.5

7.03

7.38

ug/l

0.59

140

(3017143) Hepatitis C virus Ab [Presence] in Serum

747

4167

1.95

54.69

2.1

1.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

511

2496

2.18

53.63

7.3

4.0

117.20

87.45

ng/l

5.12

457

2179

(3015736) pH of Urine

1899

13918

1.63

53.29

4.5

3.2

5.86

5.85

0.02

107

1116

(3026782) Osmolality of Urine

1108

7048

1.76

53.06

4.1

2.8

524.82

550.34

mosm/kgh2o

3.63

985

6049

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4033

36179

2.20

52.69

29.2

13.2

25.28

23.53

mg/l

3.02

3565

28355

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

265

973

2.83

51.56

1.4

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

198

618

3.31

51.08

1.8

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

327

1342

2.55

51.06

2.2

1.9

1.77

2.37

ug/l

0.55

293

1184

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

472

2290

2.19

50.25

5.8

4.2

5.23

5.14

kpa

1.32

456

2189

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

262

973

2.80

49.88

2.1

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

455

2182

2.21

49.85

5.8

4.2

1.75

1.64

mmol/l

0.21

358

1614

(40768443) Skin Pathology biopsy report

340

1440

2.47

49.63

1.4

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1780

13004

1.61

49.51

4.9

3.4

41.82

91.57

ng/l

0.74

1304

8647

(3036481) Cortisol [Moles/volume] in Serum or Plasma

606

3247

2.00

49.48

2.5

2.2

357.68

370.75

nmol/l

0.83

567

2981

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1049

6689

1.74

49.27

5.4

3.6

244.20

604.24

ng/l

1.45

816

5120

(3012516) Albumin [Mass/volume] in Urine

1437

9971

1.65

49.14

4.0

3.2

474.39

308.34

mg/l

0.68

1019

6439

(3023520) Reticulocytes [#/volume] in Blood

553

2881

2.05

48.78

3.1

2.7

68.97

69.48

e9/l

0.11

406

2183

(3009343) pH of Capillary blood

464

2263

2.17

48.69

5.9

4.3

7.41

0.19

247

(3020682) Albumin/Creatinine [Ratio] in Urine

1492

10471

1.64

48.66

4.7

3.8

17.39

8.61

mg/mmol

4.48

1006

6719

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

394

1806

2.30

48.08

12.8

9.7

24.12

24.28

mmol/l

0.46

376

1757

(3019309) Folate [Moles/volume] in Red Blood Cells

978

6154

1.75

47.96

1.9

1.7

1206.00

1165.22

nmol/l

0.60

775

4670

(3035350) Ketones [Presence] in Urine by Test strip

2228

17258

1.58

47.78

4.8

3.5

0.01

0.00

estimate

0.47

414

3445

(3021601) Nitrite [Presence] in Urine by Test strip

2222

17228

1.58

47.25

6.5

4.7

0.00

estimate

0.80

394

3283

(3011397) Hemoglobin [Presence] in Urine by Test strip

1204

8054

1.68

47.07

4.5

3.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

348

1527

2.39

46.93

1.8

1.7

1.71

1.51

g/l

2.85

306

1308

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

609

3329

1.96

46.78

3.4

2.4

33.30

50.83

u/l

0.66

532

2869

(3021589) Normoblasts [#/volume] in Blood

2066

15786

1.58

46.58

14.9

9.2

0.00

e9/l

0.00

1691

12855

(3009445) Proteinase 3 Ab [Units/volume] in Serum

333

1444

2.41

46.09

1.5

24.04

17.61

u/ml

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

335

1460

2.40

45.85

5.8

3.9

51.68

49.14

0.99

330

1443

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

240

891

2.79

45.68

1.4

13.96

15.03

iu/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

281

1132

2.58

45.52

3.4

3.8

0.33

0.34

u/ml

0.34

157

645

(3009261) Glucose [Presence] in Urine by Test strip

2232

17426

1.56

45.29

4.8

3.5

0.00

estimate

1.47

369

3153

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

686

3986

1.85

43.51

3.9

3.0

6.60

8.21

umol/l

2.29

612

3470

(3027273) Bicarbonate [Moles/volume] in Venous blood

347

1589

2.28

42.31

6.3

3.4

25.12

25.22

mmol/l

0.20

340

1534

(3014007) Fractional oxyhemoglobin in Arterial blood

428

2151

2.09

41.31

13.3

9.4

93.40

94.09

1.46

428

2143

(3037522) Nuclear Ab [Titer] in Serum

769

4697

1.77

41.13

1.4

1.3

533.51

540.04

titre

0.03

151

982

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

384

1877

2.14

39.80

13.8

10.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

504

2723

1.96

39.71

1.7

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

169

558

3.11

39.70

3.9

3.3

473.17

1401.40

u/ml

0.81

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

193

695

2.86

38.87

1.6

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

193

695

2.86

38.87

1.6

1.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1564

11564

1.54

38.64

4.4

3.3

2.35

mmol/l

0.42

1372

10233

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

862

5527

1.69

38.47

2.0

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

195

715

2.81

37.97

8.4

5.6

271.97

611.90

iu/ml

0.80

(3019550) Sodium [Moles/volume] in Serum or Plasma

4020

36811

1.93

37.47

31.7

15.2

139.30

139.67

mmol/l

16.27

3938

35851

(3024928) Oxygen saturation in Venous blood

198

737

2.76

37.47

7.5

3.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

199

743

2.76

37.44

3.0

3.1

32.17

36.27

umol/l

1.13

178

677

(3022313) Gas panel - Capillary blood

349

1691

2.15

36.93

6.0

4.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4025

36933

1.92

36.37

32.0

15.3

3.99

3.97

mmol/l

4.54

3940

35902

(3020630) Protein [Mass/volume] in Serum or Plasma

495

2738

1.91

36.21

3.3

2.6

65.75

66.55

g/l

1.42

455

2521

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3147

27260

1.52

34.38

4.5

3.9

14.62

14.73

pmol/l

1.50

2873

24859

(3052851) Hemolysis interference index of Serum or Plasma

234

991

2.44

34.01

4.2

3.1

—

(3019060) Gas panel - Arterial blood

415

2238

1.94

32.63

5.9

5.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

308

1491

2.14

32.60

6.4

4.7

24.94

24.72

mmol/l

0.54

294

1395

(3005719) IgG [Mass/volume] in Serum or Plasma

472

2700

1.84

30.87

3.2

2.7

10.74

10.53

g/l

0.43

438

2463

(46235355) HIV 1 and 2 tests - Meaningful Use set

977

6794

1.56

30.46

2.4

1.8

—

(3010375) cycloSPORINE [Mass/volume] in Blood

169

4.44

29.88

26.3

27.6

109.49

120.31

ug/l

0.71

143

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3635

32831

1.58

29.78

5.6

4.5

1.93

2.04

mu/l

0.75

3364

30166

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

500

2943

1.79

29.71

2.8

2.3

6.39

7.64

ug/l

0.75

435

2598

(3007164) IgA [Mass/volume] in Serum or Plasma

1000

7032

1.54

29.53

1.6

1.5

2.54

2.39

g/l

1.42

609

4351

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

282

1377

2.12

29.15

5.9

5.7

1.88

1.64

2.48

268

1285

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

571

3520

1.71

28.79

5.4

3.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

241

1115

2.23

28.54

1.6

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

181

740

2.51

28.38

1.4

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

675

4365

1.64

28.34

2.6

2.4

161.54

135.90

ug/g

0.76

548

3496

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2801

24105

1.44

28.32

4.4

3.0

56.00

47.52

u/l

4.90

2662

22563

(3035947) Staphylolysin Ab [Units/volume] in Serum

148

4.58

28.21

1.2

1.1

5.75

3.70

iu/ml

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

230

1051

2.25

28.06

3.6

2.8

198.29

186.27

1.20

223

1002

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

247

1163

2.19

28.01

3.4

2.9

89.89

91.16

0.37

236

1123

(3028707) Methadone [Presence] in Urine by Screen method

159

615

2.64

27.94

6.2

2.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

277

1370

2.09

27.67

6.1

5.7

0.89

0.90

0.19

264

1280

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

9.23

27.37

12.1

5.51

6.14

mmol/l

0.46

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

483

2883

1.76

27.25

3.5

2.9

248.74

185.84

ng/l

2.11

435

2607

(3036489) Thrombin time

273

1371

2.06

26.17

3.0

2.5

22.08

21.30

1.39

237

1206

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

219

1015

2.22

25.82

9.1

5.0

1.84

1.44

mg/l

5.70

205

942

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

178

761

2.39

25.34

1.9

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

379

2151

1.83

25.27

9.0

7.1

24.61

24.50

mmol/l

0.21

360

2041

(3048929) Epstein Barr virus Ab [Presence] in Serum

249

1227

2.09

25.11

1.5

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

181

783

2.37

25.10

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

229

1094

2.15

25.03

3.9

3.1

3.85

3.49

g/l

2.52

220

1032

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3682

33683

1.53

25.01

23.3

12.4

81.66

82.71

ml/min/173m2

1.63

3156

27706

(3000475) Leukocytes [#/volume] in Synovial fluid

177

760

2.38

24.96

1.7

24606.65

12051.20

e6/l

1.27

115

544

(3044941) Cell count panel - Synovial fluid

133

501

2.71

24.65

1.6

1.4

—

(3019150) Specific gravity of Urine by Refractometry

1029

7524

1.48

24.55

5.3

3.8

1.02

kg/l

0.68

147

1119

(3028026) IgM [Mass/volume] in Serum or Plasma

373

2126

1.82

24.51

2.1

1.9

1.23

1.37

g/l

0.47

346

1948

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

127

4.53

23.79

2.1

1.5

2747020.00

1309812.50

iu/ml

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

229

1116

2.11

23.78

2.7

—

(40761535) Cells panel - Urine sediment

464

2843

1.71

23.71

4.8

3.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

200

926

2.21

23.64

5.2

4.6

8.64

8.49

kpa

0.54

193

906

(3004588) Protein electrophoresis panel - Serum or Plasma

385

2241

1.79

23.57

2.8

2.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

383

2229

1.79

23.46

1.4

1.3

684.73

202.54

u/ml

2.13

356

2052

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

276

1447

1.97

23.44

2.5

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

257

1321

2.00

23.09

2.3

1.8

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

218

1055

2.12

23.05

2.0

1.6

1.16

1.17

g/l

0.11

204

1001

(3021788) Differential panel - Synovial fluid

140

561

2.54

22.94

1.7

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

663

4480

1.56

22.79

2.0

1.7

1.60

1.45

5.15

568

3963

(3025941) Bacteria identified in Stool by Culture

346

1971

1.82

22.75

1.4

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

161

695

2.37

22.46

2.0

1.5

115.59

116.61

u/ml

0.04

125

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3554

32466

1.47

22.44

7.8

5.4

42.16

39.40

mmol/mol

35.10

3302

30146

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

200

3.64

22.35

1.6

1.4

—

(3011648) Oxygen content in Venous blood

294

3.14

22.28

8.5

4.0

10.76

11.29

0.53

294

(3042733) HLA Ab [Presence] in Serum

122

4.47

22.17

4.8

4.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

210

1018

2.12

22.11

2.1

1.6

0.24

0.23

g/l

0.12

193

967

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

203

972

2.14

22.07

4.1

3.5

6.88

2.33

ratio

0.38

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

175

791

2.26

21.94

1.5

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

167

745

2.29

21.60

1.6

1.3

290.09

259.76

u/ml

0.65

118

455

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2717

23801

1.36

21.24

3.5

3.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

205

1001

2.10

21.19

4.2

3.5

75.96

114.55

mg/l

0.29

175

814

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1059

7974

1.43

21.16

1.4

1.3

1.18

1.83

u/ml

1.80

253

2114

(40761511) CBC panel - Blood by Automated count

4016

37770

1.63

20.99

24.3

12.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

204

999

2.09

20.92

4.2

3.5

37.44

66.39

mg/l

1.27

173

815

(3017181) Myelocytes/100 leukocytes in Blood

465

2951

1.64

20.68

4.8

4.1

0.90

0.91

0.05

212

976

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

192

3.58

20.63

1.4

1.3

176.00

499.44

titre

—

(3036180) Methadone [Presence] in Urine

163

3.78

20.06

3.1

1.8

—

(3037121) Protein [Mass/volume] in Urine

235

1232

1.96

19.96

5.5

3.4

0.46

0.33

g/l

0.74

133

532

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

182

870

2.14

19.89

1.5

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

441

2795

1.64

19.68

4.2

2.5

60.30

67.31

ml/min/173m2

2.54

188

1079

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

813

5900

1.46

19.61

1.3

41.94

31.92

iu/ml

0.47

235

1887

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

177

843

2.15

19.53

1.9

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

255

3.14

19.42

1.3

—

(3037756) Immunofixation for Serum or Plasma

147

654

2.29

19.17

2.0

1.7

—

(3020891) Body temperature

250

1363

1.88

18.88

6.6

4.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

194

970

2.05

18.84

1.4

248.04

281.85

ug/g

1.34

112

556

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

219

3.28

18.81

1.9

1.4

24.64

21.00

u/ml

0.32

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.93

18.68

6.0

6.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

277

3.00

18.66

1.8

1.4

1.17

1.31

promille

0.35

213

(3013512) EKG study

1243

9813

1.37

18.34

4.9

3.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

122

510

2.43

18.33

1.4

1.2

—

(3011288) Drugs identified in Urine by Screen method

195

989

2.02

18.21

6.0

2.5

—

(4200892) Spirometry reversibility

384

2399

1.66

18.10

1.5

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

127

545

2.37

18.01

2.9

3.5

1.21

1.34

0.20

114

484

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

170

824

2.11

17.95

1.9

1.7

—

(3021901) Oxygen saturation in Capillary blood

136

604

2.29

17.83

3.8

2.8

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

142

3.77

17.40

1.1

219.42

223.10

iu/ml

0.03

142

(3000330) Specific gravity of Urine by Test strip

289

1690

1.76

17.36

4.4

3.2

—

(40768804) Tissue Pathology biopsy report

1704

14202

1.32

17.25

2.4

2.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

219

1184

1.89

16.99

2.8

2.4

10.40

10.26

g/l

0.17

192

1069

(3017732) Neutrophils [#/volume] in Blood

379

2400

1.63

16.91

3.5

2.8

4.96

5.21

e9/l

0.19

292

1975

(40768446) Kidney Pathology biopsy report

141

3.72

16.79

1.9

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

214

1153

1.90

16.78

5.1

1.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

943

7235

1.38

16.30

1.8

1.7

446.74

30269003.51

pmol/l

5.44

794

6069

(3047181) Lactate [Moles/volume] in Blood

208

1124

1.89

16.17

7.3

6.5

1.30

mmol/l

0.02

189

986

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4050

38512

1.56

16.14

16.3

9.9

26.93

26.91

u/l

0.01

3949

37165

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1266

1.84

15.98

2.8

2.3

3.93

3.66

g/l

1.20

202

1161

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1267

1.83

15.94

2.9

2.3

7.52

7.37

g/l

0.64

202

1160

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

227

1267

1.83

15.94

2.8

2.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

202

1088

1.90

15.86

1.6

0.70

8.89

iu/ml

0.77

228

(40760888) Immunoglobulin light chains.free panel - Serum

153

748

2.08

15.82

4.6

3.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

327

2.66

15.77

1.3

1.1

62.12

73.95

u/l

0.58

295

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1605

13388

1.31

15.74

5.1

3.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

424

2817

1.56

15.43

5.1

4.2

0.12

0.11

0.04

177

844

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

161

810

2.02

15.42

2.6

2.2

161.48

101.64

ug/min

0.84

104

508

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

753

5609

1.41

15.40

1.3

1.2

14.27

11.75

u/ml

0.36

242

2218

(3024471) HLA-A [Type]

127

3.73

15.28

1.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

817

6182

1.39

15.24

3.2

3.0

2.46

2.45

mmol/l

2.50

697

5425

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

150

739

2.07

15.21

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

130

607

2.18

15.15

1.9

1.7

—

(3002619) Bacteria identified in Specimen by Culture

5.11

15.03

1.3

1.1

—

(3044889) 12 lead EKG panel

2745

24674

1.29

14.78

4.5

3.6

—

(3019225) pH of Specimen

488

3374

1.50

14.75

6.4

4.3

—

(3024932) HLA-DR beta [Type]

126

3.68

14.68

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

107

467

2.32

14.67

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

179

951

1.92

14.67

1.3

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

407

2711

1.55

14.63

4.7

4.0

0.81

0.70

0.28

179

851

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

125

584

2.17

14.56

1.9

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

125

584

2.17

14.56

1.9

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

407

2.41

14.53

1.5

1.4

—

(3025159) Blasts/100 leukocytes in Blood

400

2662

1.55

14.43

5.0

4.2

0.13

0.38

0.80

147

696

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

415

2.39

14.39

1.5

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

144

714

2.05

14.37

1.3

1.2

1.69

5.83

u/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

187

1015

1.88

14.36

1.3

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

413

2.38

14.08

1.5

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

336

2.53

13.95

3.2

3.5

62.47

55.95

2.09

286

(3014765) Yersinia sp identified in Stool by Organism specific culture

187

1026

1.86

13.90

1.3

1.1

—

(3045414) Leukocytes [Presence] in Urine

256

1543

1.70

13.81

2.4

1.8

—

(40768797) Stomach Pathology biopsy report

645

4768

1.41

13.66

1.4

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

107

482

2.25

13.65

2.0

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1188

1.79

13.57

2.9

2.4

3.06

2.97

g/l

0.57

184

1082

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

148

3.34

13.52

4.8

1.8

152.04

155.00

umol/l

0.02

(36660697) Celiac disease serology panel - Serum

420

2866

1.51

13.49

1.2

—

(3016879) Cocaine [Presence] in Urine

233

1378

1.73

13.47

5.5

1.9

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

392

2.38

13.35

2.1

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

186

1034

1.83

13.27

1.3

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

284

1778

1.64

13.25

3.4

2.7

0.18

0.26

e6/l

1.13

278

1730

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

143

729

1.99

13.24

4.2

1.8

0.78

0.84

nmol/l

0.37

104

613

(3002385) Erythrocyte distribution width [Ratio]

3378

31382

1.31

13.24

32.6

15.8

14.88

14.90

0.03

3339

30780

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

616

2.08

13.09

1.7

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

371

2.40

13.09

3.7

4.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

143

740

1.96

12.71

2.8

2.2

130.49

129.96

g/l

0.08

102

537

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

109

511

2.16

12.64

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

219

1297

1.72

12.61

2.7

2.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

353

2.41

12.59

3.4

2.5

0.98

1.54

g/24h

1.22

177

(3020717) Zinc [Moles/volume] in Serum or Plasma

181

3.01

12.57

2.4

1.5

13.77

25.45

umol/l

3.47

171

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

277

1752

1.62

12.41

2.6

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

578

4261

1.41

12.37

10.4

6.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

162

3.11

12.34

1.2

—

(3003181) Sodium [Moles/volume] in Urine

120

591

2.06

12.25

2.3

1.4

61.48

63.65

mmol/l

0.19

481

(3018405) Lactate [Moles/volume] in Arterial blood

207

1218

1.73

12.21

5.3

3.8

1.42

1.39

mmol/l

0.14

202

1201

(3015171) Extractable nuclear Ab [Units/volume] in Serum

218

1308

1.70

11.99

1.2

1.3

0.57

1.07

u/ml

0.59

112

(3039000) Anion gap in Blood

146

777

1.91

11.96

8.4

7.8

11.58

11.27

mmol/l

0.40

135

692

(3018572) Chloride [Moles/volume] in Blood

146

778

1.91

11.92

8.4

7.8

104.64

105.13

mmol/l

0.53

135

693

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

480

2.15

11.74

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

403

2.26

11.70

1.5

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

416

2.24

11.69

2.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

404

2.25

11.64

1.6

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

137

721

1.93

11.62

1.6

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

188

1092

1.75

11.62

2.9

2.4

0.69

0.98

g/l

0.60

158

954

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

318

2.41

11.54

3.5

2.5

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

175

998

1.78

11.52

2.7

2.2

35.64

37.86

g/l

4.53

150

890

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

239

1485

1.64

11.51

1.8

1.9

39.06

38.85

u/l

0.06

210

1329

(3005988) Vibrio sp identified in Specimen by Organism specific culture

406

2.24

11.50

1.6

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

350

2.34

11.45

1.5

1.2

—

(1616796) Gas panel - Central venous blood

144

775

1.89

11.42

6.2

3.6

—

(3000764) Benzodiazepines [Presence] in Urine

239

1490

1.64

11.36

5.4

1.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

129

3.28

11.33

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

110

541

2.06

11.30

1.2

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

315

2.40

11.30

1.4

1.3

1.28

1.49

nmol/l

0.89

281

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

384

2.26

11.27

1.6

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

135

3.21

11.21

1.1

—

(3028300) Cannabinoids [Presence] in Urine

240

1504

1.63

11.18

5.4

1.8

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

109

537

2.06

11.15

1.5

1.2

4.12

4.71

u/ml

0.21

234

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1113

9171

1.28

11.14

1.9

1.6

1.51

1.38

mmol/l

4.07

994

7746

(3027008) Opiates [Presence] in Urine

239

1499

1.63

11.10

5.3

1.8

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

169

965

1.78

11.09

1.3

1.2

15.74

42.78

u/ml

1.11

(1761482) Bacteria [#/volume] in Urine by Culture

148

813

1.85

11.03

4.7

4.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

105

513

2.07

10.99

1.2

1.1

117.63

114.66

0.37

468

(3029937) Albumin [Presence] in Urine by Test strip

1124

9291

1.28

10.94

5.5

3.9

0.00

estimate

0.06

372

3145

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

159

899

1.80

10.79

2.8

2.3

0.00

g/l

-0.00

148

836

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

351

2417

1.49

10.77

2.4

26.27

23.83

au/ml

0.12

199

(44816559) Phosphatidylethanol [Mass/volume] in Blood

128

677

1.92

10.73

1.4

1.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

393

2.21

10.68

1.3

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

263

2.49

10.63

2.8

2.7

645.23

698.26

e6/l

0.38

254

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3637

34412

1.31

10.62

5.3

4.3

6.20

5.90

mmol/l

20.20

3356

31458

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

362

2.26

10.62

2.4

2.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

847

6772

1.31

10.60

1.7

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

157

890

1.79

10.57

2.8

2.3

0.00

g/l

-0.00

147

835

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

468

3425

1.41

10.39

3.8

4.0

19.70

22.27

ug/l

0.07

377

2774

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

166

962

1.75

10.38

2.9

2.3

0.00

0.03

g/l

2.00

155

896

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

180

2.80

10.31

1.4

1.1

30.90

22.81

u/l

0.44

151

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

156

891

1.78

10.25

1.3

1.2

19.14

3.51

u/ml

0.42

(40767503) Oxygen content in Capillary blood by calculation

133

724

1.86

10.22

4.0

2.4

16.29

16.35

0.06

351

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

115

597

1.95

10.20

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

192

1164

1.68

10.20

1.7

1.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

157

902

1.77

10.12

1.3

22.34

6.40

u/ml

0.80

153

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

172

2.81

9.99

1.2

1.1

3.22

26.44

u/ml

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

116

609

1.93

9.96

6.7

2.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

322

2217

1.49

9.89

1.2

1.3

58.53

53.99

au/ml

0.12

122

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

190

2.70

9.87

1.4

1.1

104.55

88.12

u/l

0.45

162

(3002256) Pathology report gross observation

592

4540

1.35

9.84

1.4

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

106

3.32

9.70

1.7

1.6

—

(3042517) Benzodiazepines panel - Urine

8.37

9.54

2.9

2.3

—

(3027944) Amphetamines [Presence] in Urine

229

1477

1.58

9.51

5.5

1.8

—

(3010421) pH of Blood

159

934

1.73

9.51

7.7

4.0

7.41

7.42

2.77

140

850

(3009542) Hematocrit [Volume Fraction] of Blood

4177

40509

1.49

9.48

40.3

19.6

39.38

40.59

8.89

3923

38031

(3012501) Base excess in Blood by calculation

140

795

1.79

9.41

7.7

4.1

2.94

2.51

mmol/l

1.17

534

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

285

2.34

9.41

1.3

1.2

193.33

169.51

titre

—

(3022145) Colonoscopy Study observation

508

3840

1.36

9.25

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

499

1.99

9.23

1.3

1.4

22.15

24.24

u/l

0.29

414

(3009466) Valproate [Moles/volume] in Serum or Plasma

102

528

1.95

9.16

6.3

5.4

377.66

365.96

umol/l

0.36

466

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

156

922

1.72

9.14

2.0

13.29

11.23

mg/l

1.48

148

855

(3032057) Clostridioides difficile [Presence] in Stool

3.90

9.12

2.1

2.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

440

2.04

9.10

1.7

1.5

31.43

32.82

g/l

0.48

399

(3035637) Corticotropin [Mass/volume] in Plasma

456

2.02

8.97

1.5

1.6

—

(3007461) Platelets [#/volume] in Blood

4176

40541

1.47

8.95

39.6

19.5

253.84

250.04

e9/l

2.92

4100

39485

(3022493) Free Hemoglobin [Mass/volume] in Plasma

149

2.84

8.94

2.0

7.4

59.60

69.35

mg/l

0.39

112

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

107

3.19

8.89

2.9

2.1

101.67

65.30

ug/l

1.01

102

(3035941) MCH [Entitic mass]

4177

40562

1.47

8.84

39.4

19.4

30.14

30.29

5.42

4121

39981

(3024731) MCV [Entitic volume]

4177

40563

1.47

8.83

39.4

19.4

90.88

90.78

0.63

4121

39986

(3010813) Leukocytes [#/volume] in Blood

4177

40565

1.47

8.81

39.6

19.5

7.08

6.71

e9/l

18.96

4086

39385

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

208

1337

1.58

8.78

2.3

7938.66

5475.99

u/l

0.41

522

(3026361) Erythrocytes [#/volume] in Blood

4177

40569

1.47

8.76

39.5

19.5

4.42

4.52

e12/l

31.46

4094

39395

(3000963) Hemoglobin [Mass/volume] in Blood

4178

40582

1.47

8.74

39.9

19.6

131.93

136.24

g/l

57.45

4123

40002

(3016650) Hepatitis A virus Ab [Presence] in Serum

108

580

1.88

8.72

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

383

2797

1.40

8.59

7.2

3.6

1.22

1.23

mmol/l

0.05

347

2444

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

176

2.63

8.50

3.9

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

445

2.00

8.48

1.7

1.6

—

(3004775) Volume in Urine collected for unspecified duration

261

2.32

8.45

2.6

2.1

772.86

625.69

1.82

171

(3033705) Calcium.ionized [Moles/volume] in Venous blood

392

2.06

8.41

3.1

2.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3563

33876

1.26

8.36

4.6

3.8

1.38

1.30

mmol/l

8.26

3297

31185

(4035726) Immunohistochemistry procedure

410

3046

1.38

8.31

1.6

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

161

2.69

8.30

2.5

3.4

—

(1761868) Lipid panel - Serum or Plasma

1113

12986

0.81

8.28

3.2

2.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

107

584

1.85

8.23

1.1

91.41

993.67

iu/ml

0.50

138

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

305

2158

1.44

8.17

3.3

3.4

4.38

4.51

pmol/l

1.65

280

1917

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

102

550

1.87

8.16

1.5

1.2

2.82

4.23

u/ml

0.72

184

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

135

2.83

8.10

3.2

2.8

—

(3023419) Bacteria identified in Sputum by Culture

509

1.91

8.08

2.9

2.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

205

2.46

8.04

1.6

1.5

14.03

6.23

u/l

0.91

171

(3014271) Vancomycin [Susceptibility]

158

2.67

8.04

3.6

2.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

171

1072

1.62

8.04

2.3

1.8

—

(3012441) Differential panel - Pleural fluid

339

2.11

8.00

1.6

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

159

980

1.65

8.00

1.2

1.3

55.45

94.78

titre

3.28

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

469

1.94

7.98

1.7

1.4

—

(21494755) Public health laboratory ask at order entry panel

261

3701

0.69

7.89

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

465

1.93

7.84

1.5

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

417

1.98

7.81

2.0

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

417

1.98

7.81

2.0

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

259

2.26

7.72

4.0

2.8

513.80

525.81

e6/l

0.05

215

(3023199) Leukocytes [#/volume] in Pleural fluid

399

2.00

7.68

1.7

1.4

2001.69

1936.83

e6/l

0.04

296

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

169

2.56

7.57

1.6

2.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

416

1.96

7.52

1.2

1.4

344.45

332.04

pmol/l

0.07

363

(3009214) Lutropin [Units/volume] in Serum or Plasma

171

1091

1.59

7.50

1.7

1.4

8.75

9.13

u/l

0.15

135

876

(3004716) Salmonella sp identified in Stool by Organism specific culture

264

1848

1.46

7.50

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3744

35910

1.27

7.49

5.5

4.7

2.60

2.76

mmol/l

25.37

3483

33283

(21494890) Protein electrophoresis panel - 24 hour Urine

329

2.08

7.43

2.2

2.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

142

2.69

7.40

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

142

2.69

7.40

1.3

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

531

4174

1.31

7.37

4.7

4.3

32.01

32.06

0.04

392

2874

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

252

2.24

7.34

4.1

2.8

0.21

0.22

e9/l

0.07

216

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

196

2.41

7.32

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

147

911

1.63

7.27

3.1

2.4

—

(3011412) CD3 cells [#/volume] in Blood

353

2.03

7.23

3.7

2.7

1.17

1.18

e9/l

0.04

314

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

347

2.03

7.19

1.7

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

538

1.82

7.15

1.7

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

217

2.32

7.14

3.0

2.8

36.67

42.71

1.39

123

(3004616) Nuclear Ab [Presence] in Serum

431

1.92

7.13

1.4

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

230

2.28

7.11

1.3

1.2

12.17

12.53

u/l

0.05

208

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

199

2.38

7.10

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

169

2.50

7.07

1.6

2.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

101

571

1.79

7.00

1.7

1.6

—

(3024263) Appearance of Synovial fluid

170

2.48

6.99

1.2

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

102

2.95

6.95

1.5

1.3

9.09

8.88

ug/l

0.10

102

(3035320) C reactive protein [Mass/volume] in Body fluid

252

2.20

6.93

3.1

2.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

110

640

1.74

6.91

3.3

3.1

0.86

0.82

nmol/l

0.35

497

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.35

6.82

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

361

1.98

6.82

1.7

1.4

27869.47

89474.60

e6/l

1.74

215

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

137

2.64

6.79

2.9

2.3

—

(3042631) Mycobacterium sp identified in Specimen

448

1.87

6.69

3.0

2.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1098

9479

1.21

6.68

4.4

3.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

303

2.06

6.64

1.4

1.3

358.72

337.54

u/l

0.11

292

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.47

6.59

1.3

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3655

35073

1.23

6.59

5.0

4.2

1.37

1.44

mmol/l

21.16

3403

32519

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

116

696

1.68

6.54

3.8

3.5

57.05

57.79

0.23

116

696

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3678

35329

1.23

6.49

5.1

4.2

4.44

4.65

mmol/l

30.20

3447

32937

(3044927) Protein electrophoresis panel - Urine

327

2.00

6.45

1.4

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

461

1.84

6.44

2.3

1.7

10346.67

924.44

titre

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

241

2.17

6.40

1.9

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

130

2.63

6.37

1.6

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

130

2.63

6.37

1.6

2.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

487

3858

1.29

6.37

2.4

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

450

3529

1.31

6.35

1.9

1.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

217

2.23

6.28

20.1

17.9

1386.71

1431.14

nmol/l

0.16

210

(3023511) Choriogonadotropin [Units/volume] in Urine

112

674

1.68

6.26

1.5

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

415

1.87

6.26

2.1

27.24

21.13

mg/l

0.45

102

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

211

2.24

6.25

1.0

1.1

1.17

1.04

ratio

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

181

1221

1.50

6.24

3.2

3.6

1489.11

4109.05

u/ml

0.53

160

1050

(3016750) Collection duration of Urine

199

2.27

6.20

2.7

1.9

511.56

485.43

min

1.13

145

(40768806) Pleura Pathology biopsy report

346

1.95

6.19

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

376

1.90

6.10

1.6

61.06

59.74

0.09

230

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

142

913

1.57

6.10

2.1

1.4

499.85

534.48

mg/l

0.27

136

860

(3007463) Buprenorphine [Presence] in Urine

12.52

6.08

6.0

9.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

140

899

1.58

6.05

2.2

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

167

1116

1.52

6.03

1.4

1.3

151.26

218.92

miu/ml

1.87

520

(3036525) Urea [Moles/time] in 24 hour Urine

10.02

6.03

3.5

3.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.17

6.00

1.0

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.87

5.98

1.2

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

315

2370

1.35

5.93

2.3

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

531

4292

1.27

5.92

2.5

2.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

338

1.94

5.90

3.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.01

5.89

1.2

1.0

—

(3028433) Virus identified in Specimen by Culture

113

2.67

5.81

1.4

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

132

2.51

5.69

1.6

2.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

220

2.15

5.68

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1165

10243

1.19

5.66

1.4

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

268

2.03

5.61

2.0

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

6.52

5.55

3.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

249

2.06

5.54

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

249

2.06

5.54

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

249

2.06

5.54

1.1

—

(3016038) Potassium [Moles/volume] in Urine

229

2.11

5.54

2.2

1.3

41.94

34.03

mmol/l

0.84

204

(3010144) Erythrocytes [#/volume] in Synovial fluid

311

1.94

5.53

1.4

201015.88

88623.57

e6/l

0.39

218

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

10.02

5.52

7.8

7.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

263

2.03

5.51

4.4

2.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

575

1.68

5.51

1.7

1.6

0.69

0.81

g/l

0.63

444

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

223

2.12

5.50

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

113

707

1.61

5.48

1.3

1.2

31.14

38.68

u/ml

0.28

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

251

2.04

5.43

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

251

2.04

5.43

1.1

—

(3011985) Renin [Units/volume] in Plasma

450

1.77

5.42

1.4

66.37

71.30

mu/l

0.06

400

(3051611) Lipemic interference index of Serum or Plasma

342

1.88

5.39

5.3

3.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

252

2.04

5.38

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

257

1904

1.37

5.36

2.3

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

116

739

1.58

5.24

2.6

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

114

2.55

5.20

5.8

2.5

150.53

223.86

e6/l

0.84

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

120

2.51

5.19

1.3

1.2

0.28

0.29

g/l

0.18

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

146

982

1.50

5.17

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

150

1015

1.49

5.16

1.4

1.3

—

(3045788) Cell count panel - Pleural fluid

320

1.89

5.11

1.7

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

116

2.51

5.03

1.6

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

172

2.22

5.02

2.1

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

172

2.22

5.02

2.1

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

560

1.66

5.01

1.2

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

323

1.87

4.97

1.5

1.4

6.44

6.33

mmol/l

0.10

301

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

295

1.91

4.96

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

295

1.91

4.96

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

295

1.91

4.96

1.6

1.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

381

3026

1.28

4.91

2.8

2.1

12.27

12.86

nmol/l

0.73

342

2700

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

304

1.89

4.87

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.78

4.87

29.9

7.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

169

2.20

4.80

4.8

1.9

26.00

28.77

umol/l

0.69

163

(3038026) Centromere Ab [Units/volume] in Serum

285

1.91

4.77

1.3

1.2

—

50.53

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

123

813

1.53

4.76

2.1

1.4

4.14

3.73

mmol/l

1.88

114

759

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

331

1.82

4.63

2.1

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

121

2.41

4.63

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

192

2.09

4.60

1.8

1.3

1.25

1.28

nmol/l

0.05

148

(3010838) Calcium [Moles/time] in 24 hour Urine

598

1.60

4.56

1.7

1.8

4.28

4.99

mmol/24h

1.21

530

(3044009) aPTT.lupus sensitive (LA screen)

4.53

4.55

1.3

1.2

—

(21494434) Karyotype in Bone marrow

312

1.84

4.52

1.3

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

183

1323

1.40

4.48

1.8

1.7

331.23

292.38

mu/l

0.68

157

1196

(3051651) Icteric interference index of Serum or Plasma

208

2.03

4.46

6.6

3.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

258

1.91

4.39

1.8

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

157

2.17

4.33

1.0

1.1

90.07

93.32

0.26

123

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

157

2.17

4.33

1.2

1.1

1574.00

1525.89

miu/ml

0.08

157

(3000492) Spirometry study

437

3583

1.24

4.32

1.6

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

215

1607

1.36

4.31

1.5

1.4

27.76

26.99

iu/l

0.11

172

1352

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.53

4.29

32.5

6.7

—

(3022621) pH of Urine by Test strip

291

2275

1.30

4.27

3.4

2.8

—

(3008295) Osmolality of Serum or Plasma

379

1.73

4.20

1.2

1.5

277.44

280.00

mosm/kgh2o

0.43

286

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

241

1.92

4.19

1.5

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

127

2.29

4.19

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

119

805

1.49

4.17

2.6

1.5

30.76

22.44

e6/l

0.20

628

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

119

806

1.49

4.15

2.7

1.6

3810.32

1172.17

e6/l

0.36

102

659

(3003338) MCHC [Mass/volume]

3255

31279

1.15

4.12

35.5

16.9

331.15

332.94

g/l

22.12

3235

31028

(3004451) EKG impression Narrative

154

2.15

4.11

1.4

1.2

—

(3047189) Immunofixation for 24 hour Urine

161

2.12

4.08

1.1

1.8

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

269

3420

0.77

4.06

1.7

—

(3000012) Reticulocyte production index

491

1.62

4.04

2.4

2.0

—

(3006653) Thiamine [Moles/volume] in Blood

189

2.02

4.02

1.3

146.68

132.97

nmol/l

0.87

189

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

10.01

4.01

2.7

10.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

168

2277

0.73

3.98

1.5

1.4

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.44

3.98

6.7

5.7

382.00

447.93

umol/l

—

(3017704) Immunofixation for Urine

184

2.02

3.92

2.1

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

212

1.94

3.90

1.2

1.1

—

(3045424) Erythrocytes [Presence] in Urine

583

1.55

3.88

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

119

2.28

3.86

1.1

—

(4062490) Immunoglobulin typing, IgG

353

1.71

3.79

1.4

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

258

1.83

3.75

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

4.59

3.74

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

224

1.88

3.67

2.0

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

122

2.22

3.66

3.9

2.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

275

1.79

3.65

1.2

1.3

1.85

2.04

mmol/l

1.07

261

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.12

3.64

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

2.54

3.62

1.2

1.3

229.32

49.03

mu/l

1.29

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

211

1.90

3.62

1.3

1.5

4.65

7.32

u/l

2.15

184

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

291

1.76

3.60

1.7

1.5

29.24

30.54

0.09

178

(3024139) IgG subclass 3 [Mass/volume] in Serum

351

1.69

3.60

1.4

1.3

0.43

0.39

g/l

0.18

249

(3019174) dRVVT (LA screen)

3.72

3.58

1.3

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

352

1.69

3.57

1.4

1.3

2.69

2.95

g/l

0.50

250

(3027135) IgG subclass 1 [Mass/volume] in Serum

352

1.69

3.57

1.4

1.3

7.45

6.61

g/l

0.57

249

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

322

1.72

3.56

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

111

2.26

3.54

1.7

3.3

—

(3009871) Measles virus Ab [Titer] in Serum

112

2.24

3.47

1.8

1.7

—

(3045142) Bone marrow Pathology biopsy report

401

1.63

3.47

1.4

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

152

2.05

3.45

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

136

985

1.39

3.38

1.1

7.25

5.13

u/ml

0.16

133

(3013139) Helicobacter pylori Ag [Presence] in Stool

285

2294

1.26

3.37

1.3

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

397

1.62

3.36

10.4

4.9

9.10

7.22

mmol/l

2.07

331

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

476

1.56

3.34

1.1

1.53

1.50

g/l

0.23

432

(3000093) Morphology [Interpretation] in Blood Narrative

337

1.67

3.31

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.30

3.26

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

448

1.57

3.24

2.2

2.4

5.64

7.62

umol/l

0.66

322

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

207

1611

1.30

3.22

4.2

3.1

34.70

56.94

u/ml

1.81

199

1550

(3001019) Free T4 and TSH panel - Serum or Plasma

143

1912

0.74

3.16

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

193

1.87

3.14

2.1

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.47

3.12

1.8

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

4.01

3.08

1.0

1.1

—

42.38

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

195

1.85

3.06

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.23

3.05

1.8

2.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.23

3.05

1.5

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

377

1.60

3.02

3.0

1.6

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.89

3.02

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

126

2.07

3.02

1.3

1.4

18.21

15.20

pmol/l

0.22

109

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

126

2.07

3.02

4.1

2.9

—

158.93

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.29

2.99

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

720

0.59

2.99

2.1

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

107

2.16

2.96

1.2

1.5

69.26

146.32

nmol/24h

0.70

107

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.25

2.93

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

219

1740

1.27

2.92

1.1

—

152.35

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

101

2.18

2.92

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

107

765

1.41

2.92

1.1

5.17

2.38

u/ml

0.91

395

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.83

2.91

1.8

1.6

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

192

1.83

2.87

8.9

6.0

31.64

14741.26

u/ml

0.49

(3034426) Prothrombin time (PT)

123

2.04

2.81

1.3

1.2

—

(3010503) CD19 cells [#/volume] in Blood

216

1.77

2.79

1.8

2.8

1.07

0.23

e9/l

0.45

210

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

194

1.81

2.79

2.2

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

433

1.53

2.79

1.2

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

239

1.72

2.77

1.2

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.08

2.76

2.3

2.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.24

2.72

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.45

2.69

6.2

3.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

124

1648

0.75

2.68

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.22

2.67

1.1

1.0

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

470

1.50

2.67

1.3

1.2

0.29

0.30

nmol/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

635

1.43

2.67

1.1

1.36

1.96

u/ml

0.52

324

(3019977) pH of Arterial blood

190

1.80

2.66

4.1

2.7

7.41

7.42

0.19

(3003888) Timothy IgE Ab [Units/volume] in Serum

696

1.40

2.63

1.1

5.93

5.00

u/ml

0.20

375

(40758292) HTLV I+II Ab panel - Serum

2.46

2.61

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.55

2.61

1.2

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.19

2.57

2.1

1.4

11.48

13.54

g/l

0.49

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

290

2416

1.21

2.56

1.2

77.64

144.98

iu/ml

4.54

110

896

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.13

2.54

1.4

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

201

1.75

2.51

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

412

1.51

2.51

1.4

1.3

—

nmol/l

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.27

2.50

1.5

1.1

108.13

76.52

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.27

2.50

1.2

2.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

669

1.40

2.50

1.1

0.82

0.96

u/ml

0.15

293

(3035880) pH of Pleural fluid

187

1.77

2.48

1.4

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.38

2.47

77.3

5.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

430

1.50

2.46

1.3

1.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

144

1.88

2.45

2.4

126.91

159.04

nmol/l

1.06

127

(3020393) Adenovirus Ag [Presence] in Stool

2.46

2.44

2.2

1.6

—

(3025577) Chromium [Mass/volume] in Blood

204

1.72

2.40

1.9

2.0

4.14

2.23

ug/l

0.60

174

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

110

2.00

2.40

2.5

2.1

9840.80

19580.95

e6/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

125

1.92

2.35

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

206

1.70

2.33

1.4

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.95

2.28

2.5

2.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.11

2.22

1.2

1.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.11

2.22

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

114

1.93

2.20

1.2

1.3

85.92

85.64

0.01

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.50

2.18

2.1

1.8

137.25

121.92

ng/l

0.17

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.29

2.15

1.5

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1328

12430

1.10

2.14

4.7

4.8

2.22

3.50

ug/l

1.99

1186

11173

(4146454) Self-monitoring of blood glucose

348

1.50

2.09

3.0

2.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.14

2.08

1.1

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.56

2.07

6.2

3.3

—

(3023410) Appearance of Cerebral spinal fluid

365

1.49

2.07

4.1

1.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

1.98

2.05

1.5

1.2

33.77

38.43

g/l

0.60

(3017569) Oxygen content in Arterial blood

169

1.72

2.03

2.9

2.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

227

1895

1.21

2.02

1.1

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.11

2.02

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.11

2.02

1.3

1.2

93.57

70.26

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

585

1.37

2.01

1.1

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.08

2.01

1.3

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

526

1.39

2.01

1.3

1.4

0.32

0.40

nmol/l

0.51

414

(40768793) Breast Pathology biopsy report

691

1.34

1.96

1.4

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

171

1.70

1.96

3.0

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

649

1.35

1.94

1.5

1.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.57

1.94

14.3

7.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.97

1.93

7.9

4.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

258

1.56

1.92

2.0

1.9

1.71

1.95

u/field

0.14

106

(3012494) Peanut IgE Ab [Units/volume] in Serum

113

1.86

1.91

1.1

0.46

3.23

u/ml

1.88

(3008898) HLA-B27 [Presence]

157

1272

1.24

1.89

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

366

1.45

1.86

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

1.90

1.85

4.5

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

100

1.90

1.85

4.5

2.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

182

1.65

1.84

3.0

2.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

261

1.54

1.83

1.4

1.3

0.98

2.16

u/ml

0.81

142

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

206

1.61

1.82

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.17

1.82

5.8

3.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

435

1.41

1.81

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

246

1.55

1.81

1.2

—

(40768441) Liver Pathology biopsy report

255

1.53

1.78

1.9

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

116

1.81

1.78

1.2

1.1

79.18

87.45

0.45

(3001186) Copper [Moles/volume] in Serum or Plasma

1.90

1.75

1.8

1.3

17.47

16.92

umol/l

0.13

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

338

1.45

1.74

1.6

2.5

19.77

20.10

nmol/l

0.08

317

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.50

1.74

3.1

2.7

—

(3017509) Phencyclidine [Presence] in Urine

2.50

1.74

4.9

1.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

290

1.49

1.71

1.2

1.1

38.80

41.26

mg/l

0.24

238

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.06

1.70

2.2

17.61

18.37

umol/l

0.08

(3036071) Salmonella sp Ab [Titer] in Serum

118

1.78

1.70

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.50

1.66

1.1

1.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.16

1.66

5.2

4.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.16

1.66

5.2

4.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

590

1.33

1.64

1.1

—

11.79

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

630

0.70

1.63

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

107

846

1.27

1.62

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

245

1.51

1.62

1.1

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

411

1.39

1.62

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

158

1.65

1.62

1.2

1.3

153.79

160.55

mmol/24h

0.24

158

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.57

1.61

3.0

6.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

246

1.51

1.59

1.1

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.07

1.59

9.1

7.5

—

(40768795) Lymph node Pathology biopsy report

337

1.43

1.58

1.3

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.00

1.58

1.8

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.11

1.55

1.5

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

2.03

1.54

1.2

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

702

1.29

1.53

3.0

3.5

557.03

730.32

u/ml

0.14

643

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.97

1.53

1.4

1.2

25.50

25.98

g/l

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.86

1.50

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.90

1.49

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

147

1.64

1.47

1.3

12.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

155

1.62

1.46

1.2

1.1

11.55

6.43

u/ml

—

(3025130) Human papilloma virus identified in Specimen

428

1.36

1.46

1.7

1.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.73

1.43

4.2

4.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

806

0.75

1.41

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

457

1.34

1.40

1.3

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

104

1.73

1.36

1.5

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.87

1.34

3.4

2.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

120

1.67

1.34

1.8

—

(3000285) Sodium [Moles/volume] in Blood

2.13

1.33

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

107

870

1.24

1.33

1.7

1.9

3.57

4.96

iu/l

0.79

311

(40762365) Oxygen content in Arterial blood by calculation

2.04

1.32

2.7

2.6

14.14

15.15

ml/dl

0.58

(3006270) Folate [Moles/volume] in Blood

291

1.41

1.32

1.4

1.2

337.41

381.27

nmol/l

0.59

260

(3006442) Creatine [Moles/volume] in Serum or Plasma

250

1.44

1.30

1.8

1.5

79.25

84.20

umol/l

0.37

250

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.50

1.30

2.5

2.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

716

0.75

1.30

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

940

0.78

1.29

1.4

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.36

1.29

1.1

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.09

1.27

1.3

—

(3005033) Fetal Nuchal fold Thickness US

713

0.75

1.27

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

735

0.76

1.26

1.5

—

(40761536) Microorganisms panel - Urine sediment

336

3018

1.12

1.24

6.1

3.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

139

1.59

1.23

1.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.04

1.22

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

116

1.64

1.21

1.1

15.18

14.48

u/ml

0.03

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

214

0.56

1.21

1.4

1.8

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

340

1.36

1.19

1.0

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.31

1.18

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.88

1.18

1.2

3.0

1.79

2.07

mmol/l

—

(40768800) Prostate Pathology biopsy report

780

0.78

1.15

1.1

1.2

—

(3022689) Creatine [Moles/volume] in Urine

103

1.65

1.12

1.3

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

484

1.28

1.12

1.0

1.1

9.07

4.30

u/ml

0.77

194

(3039443) Prostate specific Ag panel - Serum or Plasma

787

0.78

1.11

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.26

1.10

7.9

8.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

168

1.49

1.09

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

260

1.39

1.09

1.1

—

(3001729) Color of Synovial fluid

2.19

1.08

1.3

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.19

1.08

2.9

2.3

1.14

0.63

u/field

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

227

1.41

1.07

1.0

1.1

0.49

1.13

u/ml

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.87

1.07

2.1

2.9

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.76

1.06

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

203

1.43

1.05

1.0

1.1

0.32

4.76

u/ml

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.79

1.04

2.3

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

150

1295

1.16

1.04

1.5

1.7

—

(3033799) Differential panel - Peritoneal fluid

106

1.61

1.02

1.3

2.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

230

1.39

1.01

1.0

1.1

0.79

2.86

u/ml

—

(3011544) Albumin [Mass/volume] in Pleural fluid

2.00

1.00

1.6

1.1

15.73

15.50

g/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.00

1.00

2.7

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

258

1.36

0.96

1.5

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

182

1.43

0.95

1.8

1.6

1.63

3.63

u/field

0.79

133

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

276

1.34

0.95

1.1

—

(4034850) Laboratory test

132

1139

1.16

0.94

14.4

9.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.89

0.94

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.89

0.94

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

116

0.52

0.94

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

865

0.82

0.93

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1124

0.84

0.91

1.4

—

(1002224) Polysomnography panel

171

1508

1.14

0.91

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

220

1.37

0.87

1.5

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.00

0.87

1.3

1.7

53.00

43.60

umol/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

868

0.83

0.86

1.4

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.72

0.86

1.3

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

180

0.61

0.86

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

867

0.83

0.85

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

867

0.83

0.85

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

532

1.23

0.84

1.0

1.1

8.82

3.77

u/ml

1.33

257

(4094501) Cardiovascular stress test using bicycle ergometer

941

0.84

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1067

0.85

0.81

1.4

1.5

—

(3014891) Appearance of Pleural fluid

1.70

0.80

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.73

0.79

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.82

0.79

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

594

0.81

0.76

1.2

—

(40757373) Influenza virus identified in Isolate

1.57

0.74

2.2

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.08

0.74

1.2

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.08

0.74

1.2

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

238

1.30

0.70

1.0

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

327

1.26

0.70

3.0

156.56

49.04

mg/l

1.04

247

(3025018) Bordetella pertussis Ab [Titer] in Serum

221

1.31

0.69

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.53

0.68

1.2

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.85

0.68

2.0

3.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.63

0.66

1.1

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.79

0.66

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

1.41

0.65

1.0

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

163

1.35

0.64

5.3

4.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

551

1.18

0.64

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.60

0.0

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.57

0.60

3.3

1.8

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.50

0.59

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.50

0.59

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.50

0.59

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.50

0.59

1.1

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

454

1.19

0.59

1.0

1.1

0.25

0.30

u/ml

0.10

140

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

400

3776

1.07

0.58

1.5

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

140

1.36

0.58

1.9

2.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.67

0.56

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

311

1.22

0.55

1.5

1.4

162.20

197.60

pmol/l

0.47

311

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.54

0.55

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

206

0.73

0.55

1.3

1.1

1.04

1.12

u/l

—

104

(3028717) Thiamine [Mass/volume] in Blood

1.58

0.54

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.58

0.54

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

240

1.25

0.53

1.0

1.1

7.00

10.57

iu/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.49

0.53

1.2

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

108

1.39

0.53

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.43

0.53

1.2

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

205

1.27

0.52

1.3

—

(4281824) Cell count and differential, peritoneal fluid

332

1.21

0.52

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

109

1.38

0.50

2.0

2.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.41

0.50

1.4

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.46

0.50

1.0

1.1

—

(3016228) CD19 cells/100 cells in Blood

145

1.31

0.48

1.9

2.2

14.21

9.47

0.34

140

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.52

0.48

1.0

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

245

0.77

0.48

1.2

1.3

1.48

1.55

g/l

0.34

245

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

375

0.83

0.46

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

265

0.79

0.45

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

220

1.23

0.43

1.0

—

(40765096) Chromosome analysis panel by Banding

113

1.33

0.42

1.4

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

105

1.33

0.41

1.4

1.3

53.75

54.64

0.03

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.13

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

172

0.76

0.40

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.40

0.0

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.31

0.39

2.4

1.9

39.88

27.11

pmol/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.43

0.39

1.6

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

237

0.80

0.39

1.4

1.5

8.01

7.86

mmol/l

0.08

229

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

215

0.79

0.39

1.4

1.5

—

(44786800) Granulocytes/100 leukocytes in Body fluid

1.35

0.37

2.2

1.5

24.00

15.76

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.35

0.37

1.2

1.1

1.80

1.85

umol/24h

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

157

0.76

0.35

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1021

9983

1.03

0.35

4.4

4.1

22.35

21.74

0.58

464

4758

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.35

1.0

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.35

0.32

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.33

0.32

1.3

1.2

5.43

475.16

ug/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.35

0.31

1.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.25

0.29

1.0

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

108

0.74

0.29

1.1

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

539

1.10

0.26

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

472

1.10

0.26

1.3

7.54

7.18

mmol/l

0.34

417

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

160

1.19

0.25

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

105

1.24

0.24

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.28

0.24

1.1

0.01

8.51

u/ml

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

2.33

—

(3048879) Bone marrow aspiration report

1.23

0.21

1.6

2.0

—

(3020650) Glucose [Presence] in Urine

1.23

0.21

1.2

1.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

134

0.82

0.20

1.4

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

219

0.87

0.20

6.9

6.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.20

0.19

1.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.20

0.19

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

115

1096

1.05

0.18

1.5

—

(3006462) Nitrate [Presence] in Urine

164

0.85

0.18

3.9

3.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

523

1.07

0.17

1.1

2.92

2.74

u/ml

0.07

240

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

139

1340

1.04

0.15

1.7

4.21

3.92

mg/l

0.20

110

967

(3029396) Erythrocyte agglutination [Presence] in Blood

1.08

0.14

3.0

2.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

139

1343

1.04

0.14

2.0

1.9

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

141

1.14

0.13

1.7

2.9

1.52

1.21

ug/l

0.20

130

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

1.14

0.11

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

758

1.04

0.11

3.8

3.2

30.83

26.76

mg/l

0.35

461

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

134

1.12

0.10

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.04

0.09

2.4

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.3

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.08

1.2

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.07

0.08

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.08

0.08

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.08

0.08

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.08

0.08

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

338

0.95

0.08

4.3

4.9

149.36

74.44

u/ml

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.86

0.07

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

108

1.11

0.07

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.07

0.07

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

600

0.97

0.07

1.1

—

(3020491) Glucose [Moles/volume] in Blood

265

1.06

0.07

2.5

1.6

9.46

6.67

mmol/l

1.49

179

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

718

7230

0.99

0.06

3.0

0.70

0.76

ug/l

1.27

479

4732

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

109

1.10

0.06

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

527

5236

1.01

0.05

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

322

0.96

0.04

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

229

1.05

0.04

1.0

828.93

723.18

ng/l

0.63

148

(3015183) Erythrocyte sedimentation rate

200

0.95

0.03

1.1

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

398

3957

1.01

0.03

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

320

1.03

0.03

1.5

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

231

1.04

0.02

1.0

35.72

45.61

ng/l

0.80

150

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

231

1.04

0.02

1.0

255.19

319.71

ng/l

1.11

154

(3002523) Influenza virus A Ag [Presence] in Specimen

601

0.98

0.02

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

113

1.06

0.01

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

133

1.05

0.01

1.4

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

108

1.02

0.00

1.2

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

104

0.96

0.00

4.4

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

104

0.96

0.00

2.2

3.1

—

(44813793) Dust mix specific IgE antibody measurement

236

1.02

0.00

1.2

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

127

1.02

0.00

4.9

1.3

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

1.00

-0.00

1.0

6.53

8.32

mu/l

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.96

-0.00

1.6

1.4

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.00

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.92

-0.00

1.3

1.6

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.93

-0.00

1.0

1.4

0.00

1.58

u/ml

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.8

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.3

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_INFECT_SKIN_OTHER and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_INFECT_SKIN_OTHER	2.319 [2.03, 2.65]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.336

During the follow-up period (1.1.1998 — 31.12.2019), 2422 out of 10980 females with L12_INFECT_SKIN_OTHER died.

Males

Parameter	HR [95% CI]	p-value
L12_INFECT_SKIN_OTHER	2.305 [1.95, 2.73]	< 0.001
Birth year	0.983 [0.92, 1.05]	0.608

During the follow-up period (1.1.1998 — 31.12.2019), 2964 out of 12686 males with L12_INFECT_SKIN_OTHER died.

Mortality risk

Mortality risk for people of age

years, who have L12_INFECT_SKIN_OTHER.

N-year risk	Females	Males
1	0.164%	0.433%
5	1.23%	2.133%
10	3.24%	5.789%
15	6.253%	10.672%
20	11.096%	17.629%

Relationships between endpoints

↥

Index endpoint: L12_INFECT_SKIN_OTHER – Other local infections of skin and subcutaneous tissue

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other local infections of skin and subcutaneous tissue

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints